StartupTalky

Blog

  • SaaS Content Strategies that Drive SaaS Product – Bistriti Poddar, CCO, uKnowva

    The article has been contributed by Bistriti Poddar, Chief Communication Officer, uKnowva

    SaaS or software as a service makes use of cloud technology that allows users to access the software virtually from any location with the help of a device connected to the internet. With the proliferation of the SaaS market over the past few years, SaaS providers are eyeing to develop a solid marketing strategy that helps their products to stand out from the competition. Content marketing is a big part of the SaaS marketing strategy which if used effectively can produce the desired conversions and leads. However, the challenge comes in the form of offering engaging, relative and creative content in the $157 billion SaaS market. With millions of SaaS content already available on the internet, most companies make the mistake of repeating the same content over again or bore their audience with technical jargon. However, there are ways through which one can step up their content marketing strategy. Read on to know how!

    Ways to Create an Effective SaaS Content Marketing Strategy

    Ways to Create an Effective SaaS Content Marketing Strategy

    Software as a Service Market Size Worldwide from 2010 to 2020
    Software as a Service Market Size Worldwide from 2010 to 2020

    Creating good content for SaaS requires effort and time, however, it is an investment that can provide good results and generate leads in the future. Here are some of the ways to devise to step up the content marketing strategy:

    Define the Target Audience

    The most important strategy in SaaS content marketing is to first identify the target audience. When the audience is identified, it becomes easy to create a content strategy suited for them. Identifying the audience at first is important since different people have different preferences.

    To better know the audience, businesses must look at audience metrics or surveys that were conducted previously. Alternatively, they can seek market research to understand more about the people they are targeting.

    For instance, as uKnowva provides 360-degree AI-backed HR solutions, our target audience usually includes the HR fraternity, CXOs, CHROs, CEOs of businesses, HR leaders, and decision-makers.

    Identify the Issues or Pain Points of the Target Audience

    While learning about the target audience, it is also crucial to pay attention to their issues or pain points. These are actually the issues they wish to address through a SaaS product or service. For this to happen, deeper research is required so as to visualise the main obstacles that are holding them back from realising their goals.

    We identified the pain point by analyzing the industry and surveying with the help of our entrepreneur friends. The overall aspect of business growth is dependent on the kind of effort one puts in to make it stand out from the crowd. Human resources play a crucial role in making a business grow and prosper. When it comes to workforce management, the administrative burden is often projected onto the human resources department. To ensure easy management and smooth functioning of data, human resources, and different business processes, we have developed our AI-enabled HRMS. uKnowva HRMS allows businesses to create an AI-driven and on-cloud HRMS platform for modernising daily HR activities on one platform. These include Core HR, Payroll & Expenses, Employee Management & Collaborations, Recruitment, Training and Development, and more. uKnowva HRMS is a comprehensive tool for HRs to successfully acquire, manage, develop, and engage their employees with transparency, security, and fun.

    We also emphasize a lot on addressing ongoing topical content around workplaces/HR with our perspective and industry-backed data. We inform and educate our potential customers about how HRMS can greatly transform their business functions and digitally transform their organizations. Apart from that, we create content nuggets around tapping into key questions customers may have in their minds before they opt for an HRMS.

    uKnowva HRMS – Founders | Business Model | Competitors
    uKnowva HRMS helps to systematically acquire, manage, develop, and engage your employees. Read to know about uKnowva, founder, and startup story.
    StartupTalkyPreeti Karna

    Analyse the Competition

    Competitor research is one of the key aspects of a successful content marketing strategy. However, it isn’t as easy as it sounds. Competing in the content space is totally different from competing with other companies in the SaaS space. That’s why it becomes all the more important to analyse a competitor’s backlinks as well as their content for topics and keywords. The data, when combined with intuitive browsing, can help businesses to get a better understanding of their competitor’s content marketing strategy. This data can be crucial to understanding weak links in a competitor’s content strategy, and this can be utilised to outcompete them in the market.

    We, at uKnowva, do a competitive content marketing analysis, taking a list of our content marketing competitors and following these three steps:

    • Take inventory of our competitors’ content (capture everything from blog articles to videos on and off their website. Each content type gives insight into the level of content investment, the format types their audience enjoys, and the range and relative importance of topics and keywords).
    • Evaluate content quantity and quality (Take stock of how many types of media and channels they are leveraging, as well as how frequently they are publishing that type or on which channel. We look for trends in engagement levels—shares, comments, etc.—to understand how well the content is performing.
    • Tag and analyze content topics (Tagging and analyzing the topics of each content piece helps surface content marketing gaps, which become opportunities for us).

    Besides that, we also factor in the most popular and trending/viral content assets that global organizations are pursuing in our space.

    Now, once the audience and the competition have been identified, it is time to start developing content, which takes us to our next point.

    Identify the Keywords

    Every SaaS business has its associated keywords. While developing content, it is essential to be aware of every keyword so as to make a strong impact. It is important to understand that these may not be just words that people use to search for SaaS businesses. It can be phrases as well. The Google AdWords Keywords Planner can be a good tool to understand how often people search for certain phrases on Google. Other than that, there are various other tools as well which can be used to identify what the audience is searching for.

    At uKnowva, we do our keyword research organically through Google-related searches, and we also use effective tools like Semrush and Sitechecker for audits and keyword ranking.

    Consider the Vision of the Business

    Every company has its own set of visions, which play a crucial part in its content marketing strategy. The content strategy must align with the vision of the business. For instance, if a business believes in education, then the way to go is to educate potential customers. This can involve teaching the audience about the different aspects of SaaS products or services so that they become more knowledgeable and, in turn, use a business’s product better. By empowering the audience, one can attract trust and faith in its own products or services.

    SAAS Startups: How to Find Product-Market Fit?
    Entrepreneurs from SaaS industry shared their ideas on finding the Product-market fit for their SaaS products. Read to know in detail.
    StartupTalkyPreeti Karna

    Create Relevant and Interesting Content

    Content has to be relevant and interesting so as to engage people in it. If the content fails to be interesting and out of context, the audience will quickly move over to some other content. However, this doesn’t mean that the content has to be sales-focused always. To create a position of authority in the industry, businesses can also commission white papers and research.

    One has to take the time to understand what the target audience wants to read and then create content based on the same. While blogs are the preferred method for most companies to disseminate information, podcasts can also be leveraged to create a growing interest in a SaaS service or product.

    For uKnowva, we focus on relevant brand-oriented content paired with niche PR targeting, which helps to establish ourselves as an expert in the HR tech field. The goal is to be seen in publications and blogs that write about our industry, thus, maximizing our exposure to anyone searching and reading for their terms. We work on long-form or “deep-dive” content that provides customers with in-depth answers to the questions they are searching for. Other than that, we do a lot of thought leadership content on trending popular opinions across different platforms like LinkedIn, Facebook groups, etc. Whitepapers, case studies, blogs, and Slideshare are some other mediums we use to explain a topic to an interested audience.

    Monitor the Results

    To understand how the content strategy is working, one must keep a watch on the results. Depending on the results, the content marketing strategy can be altered or adjusted accordingly to bring a valuable experience to the customers. You have to come up with a set of KPIs that you should focus on. It is different for all.

    At uKnowva, the most important KPIs that we use to gauge the performance of our content strategy are:

    • Website Traffic
    • Organic website traffic
    • Keyword rankings/blogs ranking
    • Impressions
    • Engagements
    • Link clicks
    • Views and upvotes on Quora

    Conclusion

    If all these steps are properly adhered to, businesses can certainly excel at creating a winning content strategy. With a strong content marketing strategy in place, building online credibility and brand awareness becomes a lot easier. This can help businesses to get a step closer to their strategic goals and establish a strong foothold in the market.

    FAQs

    What is the value of the SaaS market?

    In 2020, the public SaaS market had a total value of $157 billion.

    How to create an effective SaaS content marketing strategy?

    The following are the ways in which one can create an effective SaaS content marketing strategy:

    • Define the Target Audience
    • Identify the Issues or Pain Points of the Target Audience
    • Analyse the Competition
    • Identify the Keywords
    • Consider the Vision of the Business
    • Create Relevant and Interesting Content
    • Monitor the Results

    How to define a target audience?

    To better know the audience, businesses must look at audience metrics or surveys that were conducted previously. Alternatively, they can seek market research to understand more about the people they are targeting.

  • Savitri Jindal – From Commoner To Billionaire

    Yang Huiyan is no longer Asia’s richest lady, as the country’s developers, notably her Country Garden Holdings Co., are battered by China’s property crisis. Savitri Jindal, an Indian woman, who has a wealth of $11.3 billion owing to her business, the Jindal Group, which is active in fields notably metallurgy and power production, overtook Yang on July 30, 2022, in the Bloomberg Billionaires Index as Asia’s wealthiest woman. She also left behind another Chinese millionaire Fan Hongwei, whose fortune stems from the chemical-fiber firm, the Hengli Petrochemical Co.

    Savitri Devi Jindal’s life path from a housewife to an industrialist with a commoner’s heart shows us the power of women. She is a true encouragement to many women who want to start their professions but are afraid to succeed. This lady has demonstrated that when it comes to her family, a woman would go to any length to defend them. This abrupt change following her husband’s death had not left her weak in her thinking but rather resolved to achieve her husband’s goal till her final breath. She is a lady to be proud of, as well as a learning opportunity that will enable many women to live prosperous and independent life.

    Savitri Jindal is presently India’s tenth richest person. For the last five years, Forbes has continuously named her India’s richest woman. Savitri leads the organization so well because she is both a mother and a businesswoman at heart. As a result, “The Jindal Group” is now not only on everyone’s lips in India but has also made its mark on the rest of the world.

    Read this article further, to learn about the journey of Savitri Jindal, her biography, starting from her early life, her education, her current state, and much more.

    Savitri Jindal – Biography

    Full Name Savitri Devi Jindal
    YOB 1950
    Nationality Indian
    Spouse OP Jindal
    Home Town Tinsukia, Assam, India
    Occupation Businesswoman

    Savitri Jindal – Early Life, and Education
    Savitri Jindal – Family
    Savitri Jindal – Career and Life Timeline
    Savitri Jindal – In Politics
    Savitri Jindal – Awards, and Recognition
    Savitri Jindal – Social Work
    Savitri Jindal – Controversies
    Savitri Jindal – FAQs

    Savitri Jindal – Early Life, and Education

    Savitri Jindal was born in Tinsukia, Assam on March 20, 1950. Savitri married Om Prakash Jindal, founder of the OP Jindal Group, in 1970. The couple has a total of nine children. After OP Jindal died in a helicopter crash in 2005, Savitri took over as CEO of the corporation.

    She received her schooling in Assam, her native. She did not go to college. She received her diploma degree from Assam University.

    Savitri Jindal – Family

    After Vidya Devi, O.P.’s first wife and Savitri’s sister passed away, Savitri Jindal’s father arranged for her to marry entrepreneur Om Prakash Jindal when she was 15 years old. O.P., who was 20 years older than Savitri, was the father of six children from his first marriage, the oldest of whom was about Savitri’s age. O.P. and Savitri have three biological children.

    In 1970, Savitri married Om Prakash Jindal. O.P. Jindal died in a helicopter crash. Her four sons are Pruthviraj Jindal, Ratan Jindal, Sajjan Jindal, and Naveen Jindal, who are in charge of the Jindal group. She has a total of nine children.

    After O.P. Jindal died in a helicopter accident in 2005, his four sons received equal ownership of the group’s businesses, which they currently manage on their own. They were the driving force behind the conglomerate’s decision to list electricity company JSW Energy on the National Stock Exchange of India and to grow internationally by acquiring coal mines in Mozambique and iron ore mines in Chile. Her son Sajjan Jindal, who resides in Mumbai and oversees JSW Steel among other things, is in charge of the group’s most valuable assets. Jindal Steel & Power is managed by Jindal’s younger son Naveen, who lives in Delhi.

    Top 50 Richest Indians in 2022: Comprehensive List
    Here is an exhaustive list of the top 50 richest people in India in the year 2022. Read on to know more about their net worth and holdings.
    StartupTalkyAshwini

    Savitri Jindal – Career and Life Timeline

    • As a housewife – Savitri was the wife of Mr. O.P. Jindal, a well-known industrialist, and politician at the time, and the mother of nine children. Savitri Devi gained management skills by managing the household. As the heart of the Jindal family, she also had a unique ability to bring the members of the bloodline together. Despite being the wife of such a great man, Savitri Devi’s wings were always firmly planted in the ground and focused on the responsibility of looking after the family members. Her husband, Mr. O.P. Jindal, died in a helicopter mishap in North India in 2005, and this abrupt tragedy turned her life around completely.
    • As a businesswoman – Savitri Devi’s life had an abrupt jolt that caused her to leap to greater heights, from caring for the house to managing the business her husband, Mr. O.P. Jindal, started in 1952. The children of Savitri Jindal share equally in the ownership of the several businesses that make up The Jindal Group. Savitri Jindal rose to become one of the richest women in the world while managing the family company with the utmost care. After she took over, the company’s revenue increased exponentially.

    Savitri Jindal – In Politics

    She was elected to the Haryana Vidhan Sabha from the Hissar constituency in 2005. Following her election in 2009, she was once again re-elected to the district on October 29, 2013. She served in the previous administration as the Minister of State for Emergency Management, Restructuring, Reconstruction, and Housing as well as Local Urban Bodies and Housing.

    As a minister in the Haryana Vidhan Sabha, Savitri represents the Hisar Constituency. Savitri lost a lot of seats in the 2014 Haryana Assembly elections. She became the Jindal group’s Chairperson upon her husband’s death. She was also a member of the Indian National Congress political party. She is one of the richest women and one of the top 10 richest businesspeople.

    Indian Origin CEOs Ruling The World | Top Indian CEOs
    Indians have been playing a focal role in the success of technology powerhouses globally. Know about Indian-origin CEOs who are ruling the world.
    StartupTalkyAnik Banerjee

    Savitri Jindal – Awards, and Recognition

    • In 2013, he was appointed as a Cabinet Member of the Haryana Government.
    • In 2014, he was a member of the Haryana Legislative Assembly.
    • Asia One Magazine will bestow an international accolade in the field of women’s empowerment in 2021.
    • The tenth richest person in India and Asia’s richest woman

    Savitri Jindal – Social Work

    Aside from politics and business, this lady, with a touch of simplicity, focuses on social concerns. She entered the field of social care to accomplish her husband’s desire of improving the quality of life of the poor, farmers, and laborers, as well as to speak for youth and women. She says that she is determined to serve the social cause till her last breath.

    Savitri Jindal – Controversies

    • Savitri Jindal filed a complaint against the CEO of ZEE News, Samir Ahluwalia, and other top ZEE News employees before the Election Commission of India in 2014, citing the circulation of fake news on the channel and harming her professional image.
    • During an election rally in the Hisar region on 14 October, Subhash Chandra made an unfair, false, deceptive, and defamatory statement about members of the Jindal family, namely against the plaintiff (Savitri Jindal) and Congress MP Naveen Jindal.

    Bajaj Finserv Success Story | Instant Loans | EMI | Business Model
    Bajaj Finserv is a part of Bajaj Holdings & Investments Limited. The founder of the company was Jamnalal Bajaj and was founded in May 2007. Know more about the investments, business, revenue models, etc.
    StartupTalkyPurbalee Dutta

    Savitri Jindal – FAQs

    Who was the husband of Savitri Jindal?

    Late Om Prakash Jindal was the husband of Savitri Jindal.

    How rich is Savitri Jindal?

    Savitri Jindal is Asia’s richest woman.

    What is the current role of Savitri Jindal in the company?

    Savitri Jindal is the Chairman of the Jindal Group.

    What is the net worth of Savitri Jindal?

    Savitri Jindal is worth 1590 Crores USD.

  • How Did YouTube Grow in India? | What Pushes Its Growth?

    Launched on February 14th, Valentine’s Day, in the year 2005 by Steve Chen, Chad Hurley, and Jawed Karim as an online video-sharing and social media platform, YouTube’s impact on society has been unprecedented. In the last decade and a half of its existence, YouTube has influenced popular culture, and internet trends and has created multimillionaire celebrities.

    In October 2006, YouTube was bought by Google. Since then, YouTube has grown to become the second most visited website after Google Search, with more than 2.6 billion monthly users, collectively watching more than one billion hours of videos each day.

    With Google’s guidance and expertise, YouTube expanded its revenue-generating model from advertising alone to offering paid content such as movies and exclusive material produced by YouTube. It also offers YouTube Premium, a paid subscription service that allows for content watching without intervening advertisements. YouTube also approved of creators participating in Google’s AdSense program, which is aimed at generating revenue for both parties.

    Since 2006 and Google’s takeover of YouTube, it has expanded into mobile apps, network television and the ability to link with other platforms. YouTube’s video content now consists of music, short clips, news, short films, feature films, documentaries, audio recordings, movie trailers and teasers, vlogs, live streams and many more. Apart from individual content, YouTube also contains content generated from collaborations between YouTubers and Corporate sponsors. Large established media corporations like Disney, Paramount and Warner Bros. Discovery have also created and expanded their corporate YouTube channels in an effort to reach to a wider audience.

    YouTube’s Growth Story in India
    What Is Fuelling This Growth?

    How to Start a YouTube Channel in 2022?

    YouTube’s Growth Story in India

    Forecast of the Number of YouTube Users in India (2017-2025)
    Forecast of the Number of YouTube Users in India (2017-2025)

    A report published by Oxford Economics stated that Indian YouTubers have contributed more than INR 6,800 crores to the country’s economy, supporting 6,83,900 jobs in the year 2020. 90% of small and medium businesses reported that YouTube’s market penetration helped grow their client base while also contributing to employee performance due to ease of information access. As per a 2021 report, the number of YouTube channels that enjoy more than 1 lakh subscribers is approximately 40,000—a 45% increase from the year 2020. The report also states that as of June 2021, there are more than 4,000 channels on YouTube that have over 10 lakh subscribers – an increase of over 50% from 2020.

    Susan Wojcicki, YouTube’s CEO has said that India is the video streaming service’s largest and fastest-growing audience. “India is now both our biggest audience and one of our fastest growing audiences in the world. YouTube today has become the first stop for users to consume content, whether they’re looking for entertainment or information. It is this incredible variety of content combined with the growing reach that makes YouTube a perfect platform for brands to drive personalised engagement,” she said in an interview. During the same interview, she also shared that YouTube’s mobile consumption was at an all-time high of 85%, 60% of which was coming from the six largest metropolitan cities of India. Mark Patterson, CEO of GroupM Asia Pacific had referred to YouTube as a secret weapon in every Indian marketer’s arsenal.

    YouTube Success Story – Founders, Funding, Business Model, Growth, Funding and More
    YouTube is one of the biggest video sharing platforms founded by Jawed Karim, Chad Hurley, and Steve Chen. Know more about its success story
    StartupTalkyChayanika Goswami

    What Is Fuelling This Growth?

    Most Frequently Watched YouTube Video Formats in India
    Most Frequently Watched YouTube Video Formats in India

    The primary reason for this has been the increase in Content Creators. In 2014, YouTube in India had only 16 content creators with 10 lakh subscribers. In less than a decade, that number has grown exponentially to reveal an average of 2 content creators who cross 10 lakh subscribers and more than 2,500 content creators who cross the 1,000 subscriber milestone every day. Then there are Influencers, Breakout Entertainers, Creative Entrepreneurs and Utility YouTubers who are substantial contributors to this new growing economy.

    Rise of the Indian Content Creators

    Content creators unanimously agree that the growth revolution witnessed by YouTube in India over the last few years has been triggered by Jio, which made the mobile internet extremely cost-effective.

    “A lot of this growth is coming from local, native Indian languages across genres. While genres like comedy, food, health and beauty continue to rise, we are seeing tremendous growth in uniquely Indian content like village food, farming, etc.,” said Satya Raghavan, Director, YouTube Content Partnerships, India.

    95% of users on YouTube in India are consuming content in local languages. By launching YouTube Space in Mumbai and Delhi, YouTube has given creators access to production equipment and themed sets to create and produce original content for their YouTube channels.

    The Influencers

    Influencers are young and speak to the millennial audience. They create videos on everyday relatable things, usually in Hindi, and post an average of 12–15 videos a month. They enjoy a large fan following from a gender-balanced and geographically diverse audience. These are creators who collaborate with brands and engage in product or service promotions due to their wide reach. They record high earnings due to these collaborations and even the resulting sales. They also earn handsomely from YouTube.

    The Breakout Entertainers

    The advent of breakout entertainers on YouTube saw exponential growth in subscribers and viewership, for YouTube. These are single performers of stand-up comedy, dance, and other various forms of entertainment. Examples of Indian breakout entertainers are Bhuvan Bam and his channel BB ki Vines and Prajakta Koli known as ‘MostlySane’.

    The Creative Entrepreneurs

    These are creators who, regardless of their gender, enjoy a subscription of at least 10,000 users and other niche creators with lesser subscribers who generate funds from other sources through their YouTube videos. They also permanently employ other people to support their activities on YouTube.

    The Utility YouTubers

    YouTube has revealed that a most remarkable trend has emerged concerning utility and DIY videos. 71% of their online Indian viewers first watch a YouTube video to learn something. This reveals that YouTube is quickly becoming India’s ‘go-to’ place to learn a new skill.

    Says Ajay Vidyasagar, Regional Director, APAC, YouTube Partnerships – “The creator economy in the country has the potential to emerge as a soft-power impacting economic growth, job creation, and even cultural influence. As our creators and artists build the next generation of media companies that are connecting with a global audience, their impact on the economy’s overall success will only continue to accelerate.”

    Conclusion

    Satya Raghavan said, “Over the years, we have invested heavily in growing and nurturing the creator community in India and are excited to see how Indian YouTube stars now go global.” To sum it up, the Indian online video market is all set to cross USD 5 billion by 2023 and YouTube is all set to occupy a large chunk of it.

    FAQs

    When did YouTube start?

    YouTube was launched on February 14th, 2005, by Steve Chen, Chad Hurley, and Jawed Karim as an online video-sharing and social media platform.

    Is YouTube really growing in India?

    YouTube’s user base in India was recorded to be around 459.23 million users in 2021, and this number is expected to reach 833.03 million users by the year 2025, as per Statista.

    What is pushing YouTube’s growth in India?

    The following are the prominent reasons for YouTube’s growth in India are:

    • Rise of the Indian Content Creators
    • The Influencers
    • The Breakout Entertainers
    • The Creative Entrepreneurs
    • The Utility YouTubers

  • Divi’s Laboratories | Journey of Divi to become India’s second most valuable pharma company

    Company Profile is an initiative by StartupTalky to publish verified information on different startups and organizations. The content in this post has been approved by Divi’s Laboratories.

    Medicines, or drugs, or tablets, cough syrups, or pills, have become a part of our everyday lives. Have you ever thought about what would have happened if medicines were never discovered? Scary to think, right? because how else we would survive without treating different illnesses, or diseases?

    Things were very different before 1800 as to how humans used to treat and prevent diseases. Although it’s tough to put so much information in one go, we can say that the first pharmaceutical medication was produced in 1804 by Friedrich Sertürner, a German scientist.

    The establishments and inventions with curious methods of preventing many diseases provoked a lot of discoveries. As a result, the pharma industry was born with a lot of organizations indulging in manufacturing and producing drugs and medicines.

    Divi’s Laboratories with its headquarters in Hyderabad is an Indian global Pharmaceuticals company founded in 1990 by Dr. Murali Krishna Prasad Divi. The company is regarded as one of the top pharmaceutical companies for ‘custom synthesis’ and also as India’s second most valuable pharma company.

    Want to know what makes the company a custom manufacturer? then please do give a read to this article, where we cover details of Divi’s Laboratories’ success journey, who are its founders, its mission & vision, products and services offered by Divi’s Lab, its business and revenue model, what are its plans for the upcoming future and much more interesting information.

    Divi’s Laboratories – Company Highlights

    Headquarters Hyderabad, India
    Sector Pharmaceuticals
    Type Public
    Founder Divi Murali Krishna Prasad
    Key People Satchandra Kiran Divi (CEO)
    Founded 1990
    Revenue $1.2 billion (2022)
    Subsidiaries Divis Laboratories (USA) Inc, Divi’s Laboratories Europe AG, Divi’s Nutraceuticals
    Website divislabs.com

    About Divi’s Laboratories
    Divi’s Laboratories – Industry details
    Divi’s Laboratories – Founder and Team
    Divi’s Laboratories – Startup Story
    Divi’s Laboratories – Mission and Vision
    Divi’s Laboratories – Name, Tagline, Logo
    Divi’s Laboratories – Business Model
    Divi’s Laboratories CSR & Sustainability activities
    Divi’s Laboratories Covid-19 Response
    Divi’s Laboratories – Revenue Model & Growth
    Divi’s Laboratories – Shareholdings
    Divi’s Laboratories – Awards and Achievements
    Divi’s Laboratories – Competitors
    Divi’s Laboratories – Future Plans

    About Divi’s Laboratories

    Standing tall since 1990, Divi’s Laboratories is India’s second pharma company by market capitalization touching nearly $17 billion in 2021. It is one of the leading pharmaceutical companies in the world that is engaged in manufacturing Active Pharmaceutical Ingredients (APIs), Intermediates, and Nutraceuticals. The Hyderabad-based pharma company is also recognized as a Reliable Supplier of generic APIs and Custom manufacturers to Big Pharma.

    The company has two subsidiary brands namely:

    • Divi’s Laboratories (USA) Inc -located in New Jersey, USA
    • Divi’s Laboratories Europe AG – Basel, Switzerland

    Divi’s Laboratories has three manufacturing units located near Hyderabad and Visakhapatnam in India, and three R&D centers with more than 400 scientists and 42 patents across India. As the company is the world’s leading manufacturer of APIs, Intermediates, and Registered Starting Materials, it also provides high-quality goods with the greatest degree of compliance and virtue to more than 100 countries. Divi’s Laboratories was listed as a public limited business on the Indian stock exchange.

    The manufacturing zones of Divi’s laboratories have been audited by authorities such as Regulatory Authorities, several Big Pharma/Multinational Companies, Statutory Authorities, and Global Environmental, Health, and Safety teams. On top of that,  agencies such as USFDA, EU GMP (UK, Slovenia, German, and Irish authorities), HEALTH CANADA, TGA, ANVISA, COFEPRIS, PMDA, and MFDS keep have all visiting its advanced manufacturing plants in Hyderabad and Vizag for inspection.

    One of the most recent achievements of Divi’s is the distinction of being one of the top three API manufacturers in the globe, as well as one of the top API firms in Hyderabad. Divi’s Lab claims to have more than 17,000 trained people who work tirelessly to make the company the leading pharma company in India.

    Divi’s Laboratories – Industry details

    According to experts, the global pharmaceuticals manufacturing industry is predicted to expand at a compound annual growth rate (CAGR) of 11.34% from 2021 to 2028. The Indian pharmaceutical sector is expected to be worth US$ 49 billion in FY22, representing a 9% increase over FY21.

    The introduction of new technologies and efficient manufacturing types of equipment has transformed this industry massively following which, the industry is only expected to grow positively to newer heights. India is the largest contributor to exports, followed by North America, African countries, and Europe.

    Divi’s Laboratories – Founder and Team

    The founder of one of the leading APIs manufacturer companies, Divi’s Laboratories, is Dr. Divi Murali Krishna Prasad.

    Divi Murali Krishna Prasad

    Dr. Divi Murali K. Prasad was born in a small village in Andhra Pradesh. He was the youngest among his twelve other siblings.

    Dr. Divi Murali is a graduate of the Manipal College of Pharmaceutical Sciences with a degree in Bachelor of Pharmacy. His career started by working at Warners Hindustan Company. While working at Warners, Dr. Divi Murali left for America with his family during 1976-77 in search of better opportunities. Dr. Divi Murali’s entrepreneurial journey began in 1984 after he came to India after working in key research and development positions at American companies such as Fike Chemical.

    Upon returning to India, Dr. Divi Murali met Dr. Anji Reddy, the founder of Dr. Reddy’s Laboratories, with whom he bought a company called ‘Keminar’. Eventually, with the experience and knowledge, Dr. Divi Murali had gained, he finally founded his own company, Divi’s Laboratories in 1990.

    Presently, Dr. Divi Murali Krishan Prasad is the Chairman and Managing Director of Divi’s Laboratories. He is also a member of the American Institute of Chemical Engineers, American Chemical Society, and American Cosmetic Society. He was listed as the 45th wealthiest man in India in 2013 as Forbes listing. Furthermore, he was featured in Hurun India Rich List 2021 with a net worth of ₹79,000 crores making him the 14th richest person in India.

    Dr. Satchandra Kiran Divi

    Commonly known as Kiran Divi is the Whole-time Director & Chief Executive Officer of Divi’s Laboratories. Dr. Kiran Divi is the son of Dr. Murali Divi. He is also the youngest billionaire in the Telugu States with a stake of 20.34% in Divi’s Labs. Dr. Kiran Divi holds a bachelor’s degree in Pharmacy from Mangalore University and a master’s degree from Jawaharlal Nehru Technological University. Along with this, Dr. Kiran Divi achieved a doctorate from the Gitam Institute of Technology and Management. He is married to Shakuntala Divi. The pharma company has been producing high-quality company strategies and plans under his guidance, guaranteeing alignment with both short and long-term objectives.

    Nilima Prasad Divi

    Nilima Prasad Divi is the Whole-Time Director (Commercial) of Divi’s Labs. She holds a master’s degree in International Finance from the University of Glasgow, UK. She oversees Material Sourcing & Procurement, Corporate Finance, and Investor Relations.

    Ms, Nilima owns a stake of 20.34% in Divi’s Laboratories, which makes her a billionaire woman and also the richest woman in the Telugu States. Ms. Nilima also manages the company’s Material Sourcing & Procurement, Corporate Finance, and Investor Relations. Ms. Nilima developed substantial business acumen and knowledge with material need planning and finance before joining Divi’s.

    Divi’s Laboratories – Startup Story

    Divi’s Labs started as a Research & Development Centre as its core area in 1990. It grew and concentrated on inventing novel processes for the manufacturing of Active Pharmaceutical Ingredients (APIs) and Intermediates, as well as delivering comprehensive turnkey solutions and advising to the local pharmaceutical sector. Divi’s Laboratories’ brand name was changed from Divi’s Research Centre in 1994. Later after, in 1995, the business opened its first manufacturing facility in Choutuppal, Telangana. Its second production plant, located near Visakhapatnam, began operations in 2002.

    On February 17, 2003, Divi’s Labs went public with an initial public offering (IPO). In 2007, the pharma company set up a Nutraceuticals facility at its Manufacturing Unit 2, near Vishakhapatnam. After a few years, the organization opened a research center in Hyderabad in 2010. Today, the company is a leader in producing one of the highest quality APIs and other drugs and medicines.

    Divi’s Laboratories – Mission and Vision

    The vision statement of Divi’s Laboratories is, “To create value for all stakeholders by manufacturing high-quality Generic APIs, Custom synthesis of APIs & Intermediates along with Nutraceutical Ingredients to the Global Pharmaceutical & Nutraceutical industry through sustainable leadership in chemistry.” The company aims to add some significance in the area of manufacturing through its core values and serving society in general.

    Its mission is, “To be a responsible business, adding value through our core competency in the area of chemistry while adhering to our core values and serving the immediate community and at large through our diverse social initiatives that would establish a strong foundation for a better tomorrow for all stakeholders.”

    Divi’s Laboratories consists of five core business values:

    • Financial Stability
    • Reliable Supply Partner
    • Trustworthy
    • Transparency
    • Complimentary

    The name of the company is after the founder Dr. Murali Divi’s family name, ‘Divi’.

    The tagline of Divi’s Laboratories is, “Striving for leadership through chemistry”.

    Divi’s Laboratories – Business Model

    The business model of Divi’s Laboratories operates on a B2B model.

    Its business mostly engages in export markets and features a diverse product portfolio that includes generics APIs and bespoke synthesis. The company includes World-class production facilities with a total capacity of 14000 m3, one of which is the world’s largest API manufacturing plant. It has three major manufacturing units near Hyderabad and Visakhapatnam. Two huge cGMP API manufacturing machines produce thousands of tonnes of APIs that are sold to over 100 countries.

    With its motto, “Delivering a product with a value proposition, throughout the life-cycle of the product“, Divi’s Laboratories have about 400 best-in-class scientists working in their three R&D facilities across India. DRCs, Divi’s Labs Research Centres are located in Sanath Nagar, Hyderabad, while Process Development & Support Centres (PDSCs) are located at the production locations.

    There are more than 2000 employees who are assigned to Divi’s Labs Quality Assurance and Quality Control. These employees are dedicated to upholding the highest quality standards in cGMP production through frequent assessments and ongoing development of the Quality Management System. As mentioned earlier, all the manufacturing facilities are fully inspected regularly by top health agencies such as the FDA, EU GMP, HEALTH CANADA, TGA, ANVISA, COFEPRIS, PMDA, and MFDS.

    Generic APIs products

    The pharma company is a global pioneer in High Volume Generic APIs. The product list contains a highly selected 30 APIs that are commercially made in batches of tens to hundreds to thousands of Tonnes per year, thus making it the world’s largest API manufacturer.

    To name a few generic APIs products, these are Bupropion HCl, Diltiazem HCl, Gabapentin, Levetiracetam, Capecitabine, Nabumetone, Pregabalin, Quetiapine Fumarate, Valsartan, Triprolidine HCl, and many more. Some of these products are regulated by other countries like Australia, Singapore, Saudi, China, Thailand, Korea, EU Countries, and Taiwan among others.

    The company is currently developing new eight products in the therapeutic categories such as – anti-diabetic, anti-viral, anti-hypertension, anti-coagulant, etc.

    Custom Synthesis

    Divi’s Laboratories is also engaged in the business of manufacturing customized synthesis, which means it offers its manufacturing services on a contract basis for many global pharma companies. It has established relationships with 6 of the top 10 Big Pharma.

    Nutraceuticals

    Located at its Unit II manufacturing location, the Nutraceutical Facility by Divi’s is an integrated facility for the synthesis of active ingredients as well as final forms of carotenoids. It is one of the world’s leading producers of Carotenoids. The facility contains a full-service R&D, application testing, and support center. Divi’s Laboratories’ nutraceutical product line includes a complete spectrum of carotenoids such as Beta Carotene, Astaxanthin, Lycopene, Canthaxanthin, and Canthaxanthin, as well as additional completed forms such as Lutein and Vitamins, these include A, D3, D2, E Acetate, and A Palmitate. This high-quality carotenoid and vitamin components by Divi’s are used by many food & beverage, nutritional supplement, pet food, and feed sectors.

    Divi’s Laboratories CSR & Sustainability activities

    Since its inception, Divi’s has concentrated on various corporate social responsibility initiatives, affecting the lives of thousands of people living in and around Andhra Pradesh and Telangana. Its CSR initiatives include promoting education, empowering women, rural development, preventive health care, safe drinking water, animal welfare, and raising the living standards of community members.

    So far, Divi’s Laboratories have empowered more than 22,000 children by building around 206 schools and providing around 92 safe drinking water to more than 2,41,000 people in villages. Alongside, the company has executed more than 1,36,000 plantation drives in 35 villages, and more.

    The company has distributed Study material to 10th-grade students across the government schools in Andhra Pradesh, distributed Horlicks Sachets to 180 schools, and donated dual desk benches to Government schools. It has also dedicated its efforts to improving the lives of many villagers in Panthangi village in Telangana and Chippada village in Andhra Pradesh through its Model Village Project.

    Divi’s Laboratories has also dedicated itself to a sustainable environment by launching various sustainable initiatives like Water Management (installed new Sewage Treatment Plants (STPs) at manufacturing sites aided in the saving of 1,22,400 M3 of water) Energy Management (Installed advanced and energy efficient equipment – 1,08,79,000 KWH), and Waste Management (solvent recovery stations were established to recover and reuse solvents)

    Their CSR activities don’t end there. Besides, over 33,550 EHS training sessions were conducted, with 3,30,900 participants.

    Divi’s Laboratories Covid-19 Response

    In response to the pandemic, the company has been very quick to implement tight measures at its sites. Divi’s has been checking all of its business processes and production schedules, prioritizing activities of significance such as making sure appropriate behavior of its employees following all safety and sanitation protocols and ensuring its supply chain’s engagement with vendors and customers. Even though there were certain pitfalls, in the beginning, it has been able to sustain its business operations and assure an ongoing supply of active pharmaceutical ingredients to clients for the manufacture of important medications. The pharma company has also begun to vaccinate its employees and their dependents.

    Divi’s Laboratories – Revenue Model & Growth

    For Fiscal Year 2021-22, Divi’s Laboratories has been able to achieve another year of decent business growth and profitability. As the company is primarily engaged in the export market, the exports accounted for 90% of total sales income, and 77% of commerce was conducted in cosmopolitan markets such as Europe and America. The Rest of the World accounted for 4.0%, Asia for 9.2%, and India accounted for 10.0%.

    The company made a revenue of $1.2 billion in 2022. It claims to have a revenue growth of 31%.

    Revenue Distribution of Divi’s Laboratories

    Divi’s Laboratories – Shareholdings

    Divi’s Laboratories is a publicly listed company with its IPO in 2003. Its ISIN code is INE361B01024. The company has been funded by many fund managers. Some of the important ones have been highlighted in the following list:

    Fund Name Fund Manager Shares in %
    SBI Equity Hybrid Fund-Reg(G) R. Srinivasan 2.89
    Axis Long Term Equity Fund-Reg(G) Jinesh Gopani 4.60
    SBI BlueChip Fund-Reg(G) Sohini Andani 2.92
    SBI Nifty 50 ETF Raviprakash Sharma 0.65
    Axis Bluechip Fund-Reg(G) Shreyash Devalkar 1.90
    UTI Flexi Cap Fund-Reg(G) Ajay Tyagi 1.39
    Nippon India Pharma Fund(G) Sailesh Raj Bhan 7.47
    UTI Nifty 50 ETF Sharwan Kumar Goyal 0.65
    Axis Growth Opp Fund-Reg(G) Jinesh Gopani 2.25
    Aditya Birla SL Equity Hybrid 95 Fund(G) Satyabrata Mohanty 1.70
    Aditya Birla SL Pure Value Fund(G) Milind Bafna 3.19
    SBI Healthcare Opp Fund-Reg(G) Tanmaya Desai 6.89
    UTI Mastershare-Reg(G) Swati Kulkarni 1.12
    SBI Magnum Equity ESG Fund-Reg(G) Rohit Shimpi 2.12
    Sundaram Large and Mid Cap Fund(G) Ravi Gopalakrishnan 1.43
    Aditya Birla SL Pharma & Healthcare Fund-Reg(G) Dhaval Shah 6.62
    Edelweiss Nifty 100 Quality 30 Index Fund-Reg(G) Bhavesh Jain 3.04
    Motilal Oswal S&P BSE Healthcare ETF Swapnil P Mayekar 8.18
    Axis NIFTY Healthcare ETF Jinesh Gopani 10.58
    Aditya Birla SL Nifty Healthcare ETF Lovelish Solanki 10.59

    Divi’s Laboratories – Awards and Achievements

    Divi’s Laboratories has been a continuous recipient of many prestigious awards for its manufacturing, CSR, and sustainability activities. Here’s a list of awards achieved by the company in recent years:

    2022

    • Divi’s received the EHS excellence Award by CII South Region

    2021

    • Lifetime Achievement Award by ICON SWM
    • Lifetime Achievement Award for significant contribution to the circular economy and waste management by International Society of Waste Management, Air & Water (ISWMAW)
    • Divi’s received the CII-SR EHS Excellence Award 2020 – “4 Star Rating” for commitment to EHS practices
    • It has received India’s most prestigious Safety Award ‘Suraksha Puraskar Award for the year 2021 from theNational Safety Council of India (NSCI)

    2020

    • Achieved the Prashansa Patra – NSCI Safety Awards -2020 from the National Safety Council of India (NSCI)

    2019

    • Divi’s was recognized as the Best Partner – Smart Village Smart Ward by Andhra Pradesh State Government
    • CII EHS Excellence Awards 2019 – 3 star rating by the Confederation of Indian Industry (CII)
    • Divi’s Labs was recognized as the 2019 HURUN Self-made Philanthropist of the Year as per Hurun Report

    2018

    • Divi’s Labs achieved IconSWM (International Conference on Sustainable Waste Management) by the International Society of Waste Management, Air & Water
    • Achieved the May Day award for Best Management Department of Labour, Government of Andhra Pradesh

    Divi’s Laboratories – Competitors

    The top competitors of Divi’s Laboratories are:

    1. Dr. Reddy’s Laboratories
    2. Sun Pharmaceuticals Pvt. Ltd.
    3. Cipla Limited
    4. Abbott India
    5. Torrent Pharma
    6. Alkem Lab
    7. Pfizer
    8. Aurobindo Pharma Ltd.
    9. Zydus Lifesciences Ltd.
    10. Lupin Ltd.
    11. Gland Pharma Ltd.
    12. Ajanta Pharma
    13. Glenmark Pharma Ltd.
    14. P&G

    Divi’s Laboratories – Future Plans

    The company aims to expand its capacity in producing more specialized APIs to the changing marketing conditions. As the leading pharma company for manufacturing customized APIs, it further wants to expand by seeking to hit a market size of $20 billion in molecules going off-patent during FY23–25.

    FAQs

    Who owns Divi Labs?

    Divi Murali Krishna Prasad is the owner of Divi Labs.

    What is the full form of API in pharma?

    In pharma, API stands for Active Pharmaceutical Ingredient.

    Is Divi an MNC?

    Yes, Divi Labs is an MNC from India.

    Where is Divi Labs based?

    Divi Labs is based in Hyderabad.

  • Giani Ice Cream Success Story | How the company offers many options beyond just Ice cream

    Company Profile is an initiative by StartupTalky to publish verified information on different startups and organizations. The content in this post has been approved by Giani.

    Who doesn’t love the sweetened frozen food known as Ice cream? Be kids or adults, ice cream is consumed as a snack or dessert by many of us. Whether you are in the mood of having a mini celebration with your friends or even want to treat someone just to lighten up their day, ice cream comes to our mind right away.

    The origins of ice cream started around 500 BCE. In South Asia, the concept of ice cream began when the Mughals used to get ice from the Hindu Kush to its capital Delhi and used it in fruit sorbets.

    Giani, the ice cream brand we all are familiar with, is one of the oldest ice cream brands in India. Established as a small ice cream shop in 1956 by Giani Gurcharan Singh, Giani ice cream made it big and has over 200 stores across India today.

    Here’s the story of how Giani kept its legacy over all these years. Know everything about Giani’s founder, its mission and vision, its business and revenue model, and so on.

    Giani – Company Highlights

    Headquarters Delhi, India
    Legal name Giani Ice Cream Private Limited
    Sector Diary products, ice cream
    Founder Giani Gurcharan Singh
    Founded 1956
    Revenue Rs 18 crores (2019-2020)
    Website www.gianiicecream.in

    Giani – About
    Giani – Industry details
    Giani – Founder and Team
    Giani – Startup Story
    Giani – Name, Tagline, Logo
    Giani – Business & Revenue Model
    Giani – Competitors
    Giani – Future Plans
    FAQs

    Giani – About

    Giani Ice Cream, founded in 1956 in Fatehpuri, Delhi, is a company that manufactures and sells ice cream, faluda kulfi, Italian gelato, sorbet, and snacks. Its cutting-edge infrastructure, which spans 15,000 square feet in Manesar and Delhi, is divided into a variety of departments such as processing, quality testing, cold storage, and packing.

    Giani’s delicious vegetarian ice cream and snacks are enjoyed by children, teenagers, and adults alike. Their production facility has a low-temperature hardening chamber, a continuous freezer, and filling stations.

    The company can undertake pasteurization, homogenization, hardening, aging the mix, freezing, and packing at its structures under the charge of an efficient team comprised of food specialists, nutritionists, quality controllers, sales professionals, and administrative staff.

    Giani’s products are made with high-quality milk, cream, chocolate, fruits, and other natural ingredients to make for excellent nutritional value and low-fat content frozen desserts.

    The brand is prevalent throughout India, with 40 franchisee locations in Delhi/NCR alone.

    Giani also offers a personalized meal for all events to commemorate a particular occasion such as Anniversaries, Marriages, or any parties. It provides outdoor catering at a variety of places around Delhi and the NCR region.

    Giani – Industry details

    The Indian ice cream industry is expected to increase at a CAGR of 17.3 percent between 2021 and 2026. The demand for increased need for different types of ice cream flavors is what pushes the industry to newer heights. As per reports, the global ice cream market was valued at $79 billion in 2021. Furthermore, the global ice cream industry is projected to grow at a CAGR of 4.2% from 2022 to 2030.

    Giani – Founder and Team

    Giani is founded by Giani Gurcharan Singh in 1956.

    Giani Gurcharan Singh

    Giani Gurcharan Singh is the creator of the Giani ice cream shop brand. He moved to Delhi from Faislabad, Pakistan, and settled as a refugee in Delhi’s Fatehpuri, Chandni Chowk. Giani Gurcharan Singh opened the first store under the name ‘Giani Di Hatti. The business was then called Giani and slowly started developing additional branches in Delhi and other regions of North India. It was believed that Giani Gurcharan Singh had a sweet shop in Pakistan before moving to India. He even used to make all the desserts by his hand and used high-quality ingredients.

    Giani – Startup Story

    The story begins in 1956 in Giani-di-Hatti, a landmark of ancient Delhi tucked among the Fatehpuri and Chandni Chowk bazaars. Giani Gurcharan Singh, a traditional sweetmeat maker from Layallpur (Faislabad), Pakistan, started his business after relocating to Delhi.

    By making all the desserts by his hands, Giani Gurcharan Singh began serving his famed rabri-faluda and mango shakes, which he produced with great care and passion using only the highest quality ingredients. This struck a chord with the discriminating citizens of the walled city, and Giani became popular in the city.

    In 1970, the company was split into two parts: Gurcharan Sons and Giani Ice Cream. In the same year, Giani Gurcharan Singh took over Giani Ice Cream and requested his eldest son Shri Gurbachan Singh, who was still an undergraduate at the time, to join the company and add ice cream flavors to the company’s traditional sweets.

    The success of the company was due to Giani Gurcharan Singh’s commercial acumen, as well as his ability to make ice cream with his hands. It was an age when politicians and celebrities like Raj Kapoor and Mohammad Rafi would come to savour the food and take up the ambiance.

    Giani Gurcharan Singh’s three children chose to split up in 2007. Shri Gurbachan Singh, the eldest of the brothers, and his son Shri Taranjit Singh opted to continue the family heritage and kept Giani Ice Cream to develop the chain of franchise ice cream restaurants across NCR under the original brand.

    Giani Ice Cream has successfully spanned age ranges and found universal appeal among ice cream enthusiasts with over fifty locations.

    It combines the memories of Chandni Chowk’s famous and classic rabri-faluda, chilled mango shakes with the current desire for chocolate whiskey ice cream. It also has a range of sundaes, mousses, and shakes, as well as gelatos, frozen yogurts, and health-conscious inventions like jamun sorbet.

    Giani – Business & Revenue Model

    Giani operates as a franchisee-based business model. It is present in over 200 stores across states like Uttar Pradesh, Chandigarh, Punjab, Rajasthan, Haryana, Himachal Pradesh, Odisha, West Bengal, Maharashtra, Telangana, etc.

    The company is engaged in offering a wide variety of ice cream, faldua kulfi, Italian gelato, sorbet, and snacks. All of the products of Giani are manufactured under strict quality standards to provide excellent nutritional value and minimal fat content. To retain taste and freshness, ice cream is kept at the proper temperature.

    The company’s business operations also offer catering services for different occasions such as marriages, and birthday parties. Giani is reported to have made a revenue of Rs 18 crores during 2019-2020.

    During the pandemic time, the company made the best use of time to rethink and work on its packaging and menu. It introduced sealed glass jar packaging and expanded its menu to provide clients with additional options.

    Giani made a good amount of sales during Covid-19 as online orders increased because of the digital payment mode and contactless deliveries.

    Giani – Competitors

    Giani competes with the following competitors:

    1. Kwality Walls
    2. Mother Dairy
    3. Amul
    4. Baskin Robins
    5. Natural’s Ice cream:
    6. Vadilal
    7. Pabrai’s
    8. Cream and Fudge
    9. Cream Bell
    10. Havmor
    11. Haagen Dazs

    Giani – Future Plans

    Giani already has made its benchmark by having over 200 stores across India. Its objective over the next few years is to outperform all competitors as India’s leading player as an ice cream brand. It also intends to expand its international reach and target the global market in the coming years.

    FAQs

    Who is the CEO of Giani Ice-creams?

    Gurbachan Singh is the current CEO of Giani Ice-creams.

    Is Giani & Giani’s different?

    Yes, both entities are different.

    Where is the head office of Giani?

    The head office of Giani is in Delhi.

  • Zydus Lifesciences Ltd. | Success Story of India’s 4th biggest pharma co.

    Company Profile is an initiative by StartupTalky to publish verified information on different startups and organizations. The content in this post has been approved by Cadila Healthcare Limited.

    To begin, the pharmaceutical industry has shown immense growth over the years. Every pharma product goes through a series of stringent research, innovation, and regulation to deliver good quality drugs and medicines, after all, it is a matter of health.

    One cannot even imagine a life without medicines and drugs. Today, we have so many medicines for flu and fever and other key discoveries related to prolonged illnesses as well.

    Previously known as Cadila Healthcare Limited, Zydus Lifesciences Limited, an Indian multinational pharma company is primarily engaged in the manufacture of generic drugs. Founded in 1952 by Ramanbhai Patel, Zydus Lifesciences Limited has its corporate office in Ahmedabad (Gujarat), India.

    Zydus Lifesciences Limited – Company Highlights

    Headquarters Ahmedabad, India
    Sector Pharmaceuticals
    Type Public
    Founder Ramanbhai Patel
    Founded 1952
    Valuation Rs 37,991.09 crores
    Revenue Rs 15,139 crores (FY2021)
    Total Funding Raised $7 million
    Website www.zyduslife.com

    Zydus Lifesciences Limited – About
    Zydus Lifesciences Limited – Industry Details
    Zydus Lifesciences Limited – Founder and Team
    Zydus Lifesciences Limited – Startup Story
    Zydus Lifesciences Limited – Mission and Vision
    Zydus Lifesciences Limited – Name, Tagline, Logo
    Zydus Lifesciences Limited – Business Model
    Zydus Lifesciences Limited – Revenue Model
    Zydus Lifesciences Limited – Funding and Investors
    Zydus Lifesciences Limited – Mergers and Acquisitions
    Zydus Lifesciences Limited – Advertisements and Social Media Campaigns
    Zydus Lifesciences Limited – Awards and Achievements
    Zydus Lifesciences Limited – Competitors
    Zydus Lifesciences Limited – Future Plans
    FAQs

    Zydus Lifesciences Limited – About

    Zydus Lifesciences is thoroughly engaged in producing formulations for active pharmaceutical ingredients, animal healthcare products, and wellness products. Furthermore, it creates and produces a wide variety of medications, diagnostics, herbal remedies, cosmetics items, and other over-the-counter (OTC) goods.

    It is a leading Indian pharmaceutical business and a fully integrated, international healthcare provider. It has excellent capabilities across the whole pharmaceutical value chain and extensive domain understanding in the field of healthcare.

    Zydus Lifesciences has its headquarters in Ahmedabad, India. It has the fourth-place position in the country’s pharmaceutical market, with production and research facilities dispersed over five states: Gujarat, Maharashtra, Goa, Himachal Pradesh, and Sikkim. Globally, the group is well-represented in the highly visible markets of Latin America and South Africa as well as the regulated markets of the US and Europe (France and Spain). It is also well-established in 25 other developing markets throughout the world.

    Zydus is a pharmaceutical business focused on research, along with 1300 researchers operating across 19 facilities on its innovation program, which is developing distinctive medications for the future. NCEs, vaccines, biosimilars, and specialized technologies are just a few of the ideas and concepts the group is studying while also constantly inventing.

    Zydus Lifesciences has four major subsidiaries, these are:

    • Zydus Wellness Limited (ZWL) – The company re-launched the Complan  brand with improved taste and packaging design
    • Lipaglyn Saroglitazar – A new drug in treating Diabetic Dyslipidemia
    • Exemptia Adalimumab –  It is an anti-inflammatory drug
    • ZyCoV-D – The Drugs Controller General of India (DCGI), Government of India, granted the company authorization to undertake human trials of the developing COVID-19 vaccine dubbed ZyCoV-D in 2020.

    Zydus Lifesciences’ CSR & EHS initiatives

    The company’s aims and business operations include a commitment to environmental conservation, employee health, and safety. It has a dedicated Environment, Health, and Safety (EHS) cell that works with all stakeholders across functions to create a distinct EHS culture to achieve environmental, health, and safety excellence across all units.

    Zydus Shrishti, the company’s CSR initiative, focuses on health, education, and research. The Zydus Foundation has established the Zydus Medical College and Hospital in Dahod. The hospital provides free care for patients, including OPD, hospitalization, all investigations, operations, anesthesia, oral drugs, injectables, and meals.

    It has also set up a medical college in Dahod, which is a self-financed brownfield medical college project established under the Government of Gujarat’s Public Private Partnership (PPP) model.

    Zydus has conducted over 3000 awareness sessions on the prevention of various disease conditions.

    Zydus Lifesciences Limited – Industry Details

    The pharmaceutical business is massive, with a global market of more than US$ 1.4 trillion. Moreover, COVID-19 increased worldwide drug consumption, owing to fast immunization and the development of novel treatment options. Global COVID-19 investment is estimated to approach $80 billion in 2021, with total spending exceeding $251 billion through 2026.

    Nevertheless, India is a prominent and expanding player in the global medicines market. It is no surprise that India is the world’s largest provider of generic pharmaceuticals, accounting for 20% of global supply by volume and fulfilling over 60% of global immunization demand.

    Zydus Lifesciences Limited – Founder and Team

    Zydus Lifesciences Limited was founded by Indian chemist, Ramanbhai B. Patel in 1952.

    Ramanbhai B. Patel

    Ramanbhai Patel was born in South Gujarat in Kathor on 19 August 1925. Before working as an instructor there, he was a student of chemistry at Gujarat University’s L.M. College of Pharmacy. He founded Cadila Laboratories with his school friend Indravadan Modi in 1951. However, due to some disagreements, the business split in two in 1995; Raman Patel established Cadila Healthcare, and Modi established Cadila Pharmaceuticals. The 2019 Gandhi Mandela Peace Award was hosted by Ramanbhai Patel. Ramanbhai Patel passed away on 19 September 2001 in Mumbai, India.

    Pankaj R. Patel

    Pankaj Ramanbhai Patel is a multimillionaire businessman. He was born in 1953 and is the Chairman of Cadila Healthcare, now known as Zydus Lifesciences. He has a Bachelor of Arts in Science and Law from the University of Mumbai, and a Bachelor of Pharmacy and Master of Pharmacy degrees from Gujarat University. Pankaj Patel joined Cadila Healthcare, which was established by his father, Ramanbhai Patel in 1952 to produce vitamins, after receiving his degree.

    Pankaj Patel serves as the chairman of the boards of governors of the Indian Institute of Science Education and Research in Kolkata and the Indian Institute of Technology in Bhubaneswar. He is also a member of the boards of governors and the chairman of the finance committee of the Indian Institute of Management in Ahmedabad, the chairman of IIM Udaipur, the chairman of the school of life sciences at Ahmedabad University, and the board of management of the Ahmedabad University.

    In honor of the expansion of Cadila under his direction, Pankaj Patel was named the “Best Pharma Man of the Year of 2003” by the Foundation of Indian Industry and Economists. Pankaj Patel is married to Priti Patel and has two children.

    Zydus Lifesciences Limited – Startup Story

    The story begins when Ramanbhai Patel and his business partner Indravadan Modi established Cadila in 1952. Over the subsequent forty years, it developed into a well-known pharmaceutical corporation.

    In those years, Isopar, a combination of the anti-tuberculosis medications isoniazid and para-aminosalicylic acid, was produced in 1957, and Neuroxin-12, a single-vial mixture of vitamins B1, B6, and B12, was produced in 1959.

    Things got changed when the Modi and Patel families separated in 1995.  The Modi family’s portion was transferred to a new business called Cadila Pharmaceuticals Ltd., while Cadila Healthcare Ltd. became the holding company for the Patel family. In 2000, Cadila Healthcare under the stock number 532321 had its first public offering on the Bombay Stock Exchange.

    Under the trade name Exemptia, Zydus Lifesciences introduced the first adalimumab biosimilar in 2014 at a price that was one-fifth that of the original. Saroglitazar, a medicine based on research, has also been made available by the company under the trade name “Lipaglyn” for the treatment of diabetic dyslipidemia. Zydus introduced SoviHep, the first sofosbuvir brand, to India in 2015.

    2019 saw the recall of injectable ketorolac tromethamine produced by Zydus (Cadila Healthcare) owing to microbial development.

    Zydus Lifesciences Limited replaces Cadila Healthcare Limited as the company name in 2022.

    Zydus Lifesciences Limited – Mission and Vision

    The mission statement of Zydus is, “To unlock new possibilities in life sciences through quality healthcare solutions that impact lives.”

    Zydus’s vision reads, “To be a global life sciences company transforming lives through pathbreaking discoveries.”

    The company aims to give people the independence they need to lead healthier, and more contented lives.

    Before Zydus Lifesciences, the company was popularly known as Cadila Healthcare Limited. The tagline of Zydus Lifesciences is, “Dedicated to Life”

    Its new logo depicts a stylized representation of two hearts with the word “Us” in the middle. Zydus’s logo colors are vivid and deeply symbolic highlighting the fact that everything the company does is for them which is “Us”, which includes the company’s diverse group of stakeholders, including staff members, patients, carers, partners, and customers.

    The teal color in the logo expresses the company’s dynamism and purple symbolizes its purposefulness and dedication.

    Zydus Lifesciences Limited – Business Model

    As mentioned earlier, Zydus is mainly involved in the manufacturing of generic drugs, APIs, Animal healthcare products, and other OTC goods. The company has a global manufacturing footprint of 35 facilities that adhere to strong regulatory compliance requirements and have the capacity to manufacture multiple dosage forms at scale, allowing it to provide clients globally with cost-effective and high-quality pharmaceutical goods. About 7-8% of its annual revenues are invested in research and development.

    Here’s taking a look at Zydus’s main business operations:

    • Zydus Research Centre (ZRC) is the company’s specialized unit in charge of driving its NCE research efforts. Cardiometabolic illnesses, inflammation, fibrosis, and infectious diseases are among ZRC’s NCE research priorities.
    • The Company’s vaccine development projects are housed in the Vaccines Technology Centre (VTC) in Ahmedabad. VTC has been working on vaccines for basic vaccination programs such as Diphtheria, Pertussis, Tetanus, Haemophilus Influenzae type B, Hepatitis B, Measles, Mumps, Rubella, Varicella, Influenza, and Typhoid fever, as well as new vaccines such as Human Papilloma Virus, Leishmaniasis, Malaria, Haemorrhagic Congo Fever, Ebola, and Japanese Encephalitis.
    • Specialty and Complex Generics. The Company’s Specialty portfolio is focused on offering value-added therapies that meet unmet requirements while also providing patients and providers with a viable economic opportunity.
    • The company has one of the most complete and diversified biological product portfolios. The portfolio includes therapeutic fields like oncology, autoimmune illness, nephrology, ophthalmology, and other fields, including rheumatology, inflammation, hepatology, infectious illness, etc.
    • The group’s generic pharmaceutical development R&D operations are carried out in three Pharmaceutical Technology Centres (PTC) in Ahmedabad, India. These Centers provide formulations for worldwide markets, with a focus on specialty dosage forms and the development of skills on multiple technological platforms.

    Zydus’s India Business

    The company’s domestic’s business is divided into three major business segments; specialty business, chronic business, and mass business. It was the fastest growing company in India in the oncology sector while maintaining a leadership position in the super specialty of nephrology. To prevent and treat a variety of diseases in the fields of oncology, hepatology, nephrology, rheumatology, ophthalmology, and bone health, Zydus Biologics, a super-specialty centric business entity of Zydus Lifesciences Ltd., manufactures and commercializes both small molecule, biological drugs, and vaccines. It has launched around 37 new products including line extensions, out of which 13 were first in the domestic market.

    Domestic sales increased by 7% to Rs 19,788 million, with a 160% increase in net profit to Rs 3,089 million. (FY2021-2022)

    Zydus’s USA Business

    Zydus Lifesciences has been ranked 5th among US generic companies based on prescriptions. The company’s business involved the launch of  14 products during 2021-2022. Despite growing competition and pricing pressure, the company tends to gain total volume and maintained a top three ranking in around 60% of product families. In terms of volume, the company led in around 20% of the product groups. Sales made in the USA were reported to be Rs 58,138 million.

    Zydus’s Asia, Africa, and Latin America Business

    With 30 products classified as leaders in their respective molecular categories, the company reclaimed first place in Sri Lanka with a 7.4% market share. Zydus’s international business sales increased by 17% to Rs 11,921 million.

    Zydus Lifesciences Limited – Revenue Model

    The total revenue made by Zydus Lifesciences is reported to be Rs 15,139 crores. It claims that its total income from operations grew by 6% to Rs 152.7 crores from Rs 144 crores last year (2020-2021). There was a 21% Y-o-Y increase in the branded business (excluding sales of COVID-related products, the generics portfolio, and sold brands). Twelve of the company’s products are among India’s top 300 pharmaceutical brands. During 2021-2022, eight brands had sales above Rs 100 crores, 22 brands had sales between Rs 50 and Rs 100 crores, and 36 brands had sales between Rs 25 and Rs 50 crores.

    Zydus Lifesciences Limited – Funding and Investors

    Zydus Lifesciences Ltd. has three joint ventures. Some of these are;

    • Zydus Takeda Healthcare Pvt. Ltd. – It is a 50:50 joint venture between the Company and Takeda Pharmaceuticals Co. Ltd., (Japan)
    • Zydus Hospira Oncology Pvt. Ltd – It is a 50:50 contract manufacturing joint venture between Zydus and Hospira Inc., USA (now part of Pfizer group)
    • Bayer Zydus Pharma Pvt. Ltd. –  Bayer (South East Asia) Pte. Ltd. (wholly owned subsidiary of Bayer AG, Germany) and Zydus Lifesciences Limited have a 75:25 marketing joint venture.

    Zydus Lifesciences Limited – Mergers and Acquisitions

    Zydus Lifesciences has raised a total of $7 million in investment. It was funded by Baring Private Equity India in a Post-IPO Equity round.

    Zydus Lifesciences Limited – Mergers and Acquisitions

    Till now, Zydus has purchased three businesses. Windlass Biotech was their most recent purchase as of August 13, 2018. For Rs 160 crores, they bought Windlass Biotech. Windlass Biotech is Gurgaon-based healthcare that engages in pharmaceutical drug development and contract research services. Here is the list of acquisitions made by Zydus:

    Date Acquiree name Amount
    August 13, 2018 Windlass Biotech Rs 160 crores
    January 19, 2017 Sentynl Therapeutics, Inc. –
    December 22, 2011 Biochem Pharmaceuticals –

    Zydus Lifesciences Limited – Advertisements and Social Media Campaigns

    Recently, Zydus Lifesciences re-launched the popular energy drink of children ‘Complan’ with improved taste. It was accompanied by the tagline “Ummeedo se aage badhne ka plan” campaign, which communicates the crucial advantages of the brand. The advertisement focuses that if children consume Complan it will not only improve their growth but also their memory and attention.

    Zydus Lifesciences Limited – Awards and Achievements

    The list of awards and achievements won by Zydus Lifesciences are;

    • Zydus received the IDMA Aptar innovation of the year award and Corporate citizen award (2022)
    • Pharma Company Of The Year Award by ETHealthworld India Pharmaworld Awards 2022
    • Zydus achieved the HR Asia award in the category of Best Companies to work in Asia 2021 in the India region.
    • Zydus was declared the most Innovative Pharmaceutical Company by Thomson Reuters.
    • Zydus received the 7th India Pharma and India Medical Device award by the Government of India (2021-2022)
    • Zydus was recognized for Excellence In CSR at ETHealthworld India Pharmaworld Awards 2022.
    • Zydus Lifesciences was recognized as India’s Best Workplace in Biotechnology and Pharmaceuticals by Great place to work 2022.

    Zydus Lifesciences Limited – Competitors

    The list of top competitors of Zydus Lifesciences is:

    1. Dr. Reddy’s Laboratories
    2. Sun Pharmaceuticals
    3. Divi’s Laboratories
    4. Cipla Limited
    5. Torrent Pharma
    6. Glenmark
    7. Abbott India
    8. Alkem Lab
    9. Aurobindo Pharma Ltd.
    10. Lupin Ltd.
    11. Ajanta Pharma
    12. Pfizer

    Zydus Lifesciences Limited – Future Plans

    Zydus Lifesciences Ltd. recently announced the acquisition of up to an 11.86% stake in AMP Energy Green Nine. The company is also planning to launch Lenalidomide capsules, which is a cancer treatment medication that works in slowing or preventing cancer cell proliferation in the USA market.

    FAQs

    Who is the CEO of Zydus?

    Tarun G Arora is the CEO of Zydus.

    Is Zydus a public company?

    Yes, Zydus is a public company.

    Where is the headquarter of Zydus Lifesciences?

    The headquarter of Zydus Lifesciences is in Ahemdabad.

    What is the rank of Zydus in India?

    In Ind, Zydus ranks as the 4th biggest pharma company.

  • Best 10 Resources to Learn the Art of Copywriting

    Copywriting is the art of attracting customers by writing impressive sales or ad copies and persuading them to buy a particular brand’s product. Copywriting has become a crucial part of the globe. This is the reason why there are countless opportunities and employment present in the field of copywriting.

    There are many resources available in the market that boast of being the best copywriting resources. But we have searched and unfolded some valuable resources that will help you to start from scratch and further enhance your copywriting skills. Let’s dive in to see what these worthwhile resources are.

    Best Resources to Learn Copywriting

    How to Get Started With Copywriting?

    Best Resources to Learn Copywriting

    Content Marketing Revenue Worldwide (2018-2026)
    Content Marketing Revenue Worldwide (2018-2026)

    Copywriting is one of the most demanding skills in today’s world. Almost every brand and company is looking for an efficient copywriter that can help their brand build a strong image and attract more customers. So, if you are someone who wants to learn the art of copywriting, the following are some of the best resources that will help you in your learning:

    CopyHackers: The Ultimate Guide to No-Pain Copywriting

    CopyHackers - Best Resources to Learn Copywriting
    CopyHackers – Best Resources to Learn Copywriting

    The Ultimate Guide to No-Pain copywriting by giant, CopyHackers is a non-hefty but valuable copywriting resource that leverages several significant copywriting formulas. It is a kind of blog post that has a reading time of 59 minutes. You can also watch the academic video if you are not a reading person. It advises copywriters in its first lecture on how to write from scratch.

    Here, you will come across a testimonial formula, TEASE and handsome techniques on how to become a great marketer to millennials using effective marketing resources such as social media, user-generated content, experts, advertising, values, recommendations, electronic devices, etc. The PAS formula is also included to help you write an influential Facebook or Google Ads copy.

    ConversionXL: Quick Course On Effective Website Copywriting

    ConversionXL - Best Resources to Learn Copywriting
    ConversionXL – Best Resources to Learn Copywriting

    ConversionXL provides a course to master influential website copywriting. It lays stress on writing ad copies that convert the viewers into real customers. It procures an overall framework that contains several tips, tricks, techniques, and formulas for website copywriting. The framework also comprises constructive competition, product, and customer research.

    “Be specific” is one of those simple, straight but important suggestions written in ConversionXL. The virtual or real-life examples and stories introduce a factual lesson in ConversionXL.

    For instance, the skill of copywriting is pretty similar to the story of a repairman who charges a handsome amount for the work done in mere five minutes. He is able to charge that amount from the customers because he knows exactly where to hit the pipe. Similarly, a copywriter should do pre-work before the actual writing and find points to hit the target audience similar to a repairman.

    Smart Blogger by Jon Morrow

    Smart Blogger by Jon Morrow - Best Resources to Learn Copywriting
    Smart Blogger by Jon Morrow – Best Resources to Learn Copywriting

    When we are talking about copywriting resources, then how can we forget Jon Morrow, whose headline hacks instantly stop our minds and persuade us to read the write-up further? It can be his posts or audio in his voice, everything is worth reading or listening to.

    Here is an example of a headline from John Morrow Redux: “20 Ways to be Just Another Mediocre Blogger Nobody Gives a Crap About”. The headline shows a completely different perception which doesn’t present the usual 20 ways to become the best mediocre blogger. Jon is the founder and CEO of Smart Blogger, one of the greatest sites offering advice on writing and blogging. On this site, you will find everything related to the world of writing that will help you attain success in the field. Smart Blogger by Jon Morrow is thus, one of the best resources for learning copywriting.

    Khan Academy: Pixar in a Box

    Khan Academy: The Art of Storytelling - Best Resources to Learn Copywriting
    Khan Academy: The Art of Storytelling – Best Resources to Learn Copywriting

    Khan Academy has decided to bring their behind the scene stories which is a golden resource to catch up for a copywriter. Why Pixar? Because it has been nominated 211 times for awards and won 210 times for only 17 feature films they have ever created.

    Khan Academy introduces the most significant part of copywriting, which is the art of storytelling. People often remain less interested in learning about precautions to deal with cybercrime and tend to ignore them. On the other hand, people show some interest in reading further if the write-up furnishes that cybercrime happened to some big celebrity or their account got hacked.

    Digital Copywriter by Copyblogger

    Digital Copywriter by Copyblogger - Best Resources to Learn Copywriting
    Digital Copywriter by Copyblogger – Best Resources to Learn Copywriting

    Copyblogger’s Digital Copywriter provides yearly access to all its valuable educational content for $440 per year. Quite expensive, but it introduces you to copywriting from scratch. The course delivers an SEO master class, content writing master class, online business master class, email writing master class, or further advanced seminars or master classes.

    A new session is introduced every month. To refine your skills, Digital Copywriter also arranges question and answer sessions, AMAs, and auxiliary lessons on guest posting. You can also get a refund of fees if you find out that you don’t need this course anymore within a period of 30 days.

    Copywriting For Beginners by Skillshare

    Copywriting For Beginners by Skillshare - Best Resources to Learn Copywriting
    Copywriting For Beginners by Skillshare – Best Resources to Learn Copywriting

    Powered by Skillshare, Copywriting For Beginners is another copywriting resource designed specifically for beginners. If you are a newcomer looking at a blank screen and thinking about what you should start writing to persuade your client’s target audience, this course is for you.

    A 16 short sessions comprise one hour class with each session created with different headlines and assignments. It presents some life examples of successful templates and how to implement them. Moreover, you will learn about the term writer’s block and tips to fight this block. Organizing CTAs, researching the target audience, and composing subheads are other discourses you will come across in “Copywriting For Beginners”.

    The Complete Copywriting Course by Udemy

    The Complete Copywriting Course by Udemy - Best Resources to Learn Copywriting
    The Complete Copywriting Course by Udemy – Best Resources to Learn Copywriting

    Another useful resource for copywriting is Udemy’s “The Complete Copywriting Course: Write to sell like a Pro”. Despite sessions to write effective copies for your online business, you will also get free tools, free templates, and countless copywriting formulas.

    The course is committed to developing the psychology of copywriters to think like their target audiences. The plus point is its unlimited access to educational resources, which include PDFs, guides, and video sessions on successfully implemented copywriting strategies.

    Udemy: E-learning Platform | online courses
    Udemy is an online learning platform for learners. Read the success story of Udemy, and know about Udemy online courses, Udemy Business Model, and more.
    StartupTalkySarika Anand

    Blackford Centre for Copywriting

    Blackford Centre - Best Resources to Learn Copywriting
    Blackford Centre – Best Resources to Learn Copywriting

    The Blackford Centre claims to offer the best copywriting course in the world. It offers a diploma in copywriting, which is worth adding to a copywriter’s resume.

    The focus remains on writing copies that earn a handsome income. This allows you to learn and build your portfolio by working on real-time assignments. So, if you want to have real-world exposure while learning, then the Blackford Center is an expensive but perfect solution to master copywriting.

    Kopywriting Kourse

    Kopywriting Kourse - Best Resources to Learn Copywriting
    Kopywriting Kourse – Best Resources to Learn Copywriting

    This is one of the best resources to learn copywriting. It offers various tips and tricks that will allow you to understand the skill of copywriting and make the most of it. The best thing is that it even offers a free copywriting course that contains a few videos that will help you learn the basics of copywriting in just a few minutes.

    With the help of Kopywriting Kourse, you will be able to learn how you can write as you talk and how you can persuade the audience with your words. It covers aspects like creating effective emails for sales prospects, the process of creating content that converts, and more.

    The Copywriter’s Handbook

    The Copywriter's Handbook - Best Resources to Learn Copywriting
    The Copywriter’s Handbook – Best Resources to Learn Copywriting

    The Copywriter’s Handbook is a guidebook that has profited copywriters for several years. The handbook’s success made the author release its 4th edition. “A copy that sells” is the official motto of the Handbook. You can get a hard copy of this handbook on Amazon or you can also read it on Kindle to learn the various tips and tricks of copywriting.

    This handbook can benefit ingenious directors, marketing managers, multi-platform marketers, freelance writers, copywriters, and MSME owners who want to kickstart their digital businesses. It also comprises tips and methods to write effective headlines, emails that get higher click-through rates, and also tips to increase conversion rates on landing pages.

    Creative Live

    Creative Live offers a special ‘Build Successful Creative Blog’ course for young copywriters to learn the skill of planning content in a manner that compels whoever reads it to purchase from the respective business. The main part here is to teach Copywriting and the remaining helps them learn how to plan their content in an ideal manner.

    The plus point here is for women as the course is taught by female entrepreneurs. They have amazing tutorial videos on how to get to the right stuff in copywriting.

    ‌‌Creative Live offers this course in an absolutely right manner with tutorials, videos, and in-depth discussions.

    Domestika

    The course “Copywriting for social media” offered by Domestika is considered one of the finest and high-quality learning resources for copywriting in the social media genre. The course is taught by Paul who is a great teacher as well as a communicator.

    Here at Domestika, you’ll learn how with the help of the right words you can convey your brand’s story using basic writing tools. It helps you create campaigns for your client and captures the audience’s attention on social media.

    YouTube

    When it comes to learning resources, Youtube can never be missed. For copywriting, the playlist of Copywriting Persuasion Challenge which is available on YouTube is quite effective. It helps you learn copywriting with the help of writing tools and techniques which specifically target newbie writers and small business owners. It is taught by Jon Bensen who has great years of experience in the industry.

    ‌‌Here, you get to learn through practical and real-time examples that help you master a certain niche. It also helps the copywriters to step up their game and different tips & techniques.

    LinkedIn Learning

    With the growing popularity and benefits of LinkedIn to seek jobs, it’s a great place to learn new skills as well. Such as for copywriters, the “Learning to Write Marketing Copy” course is quite a popular one. It has detailed information on copywriting, plus an opportunity to work on a real project to shape your skills.

    It is presented by Ian Lurie who has taught the technique of writing content that sells in a very simple manner. Also, here you’ll learn multiple copywriting styles and the benefit of pen-down a paper.

    ‌‌This specialized course provides a single project to the learner and how to take it to the ultimate finish. You also get to work with a designer and learn typography. The main objective here is to teach marketing-based copywriting.

    What Is LinkedIn Learning and Who Is It For?
    LinkedIn Learning is an online educational platform that offers multiple courses. Continue to read to know more about LinkedIn learning platform.
    StartupTalkyIpsita Acharya

    Alison’s Courses

    For newbie writers, finding a free and good learning course is always a great deal. Among those, Alison’s Courses are quite famous. As the course is free, all you have to do is just register and get started!

    It’s not just a great deal for copywriters, but also if you’re interested in learning social media management, communication skills, content writing, and language skills, Alison’s Courses is one of the perfect platforms for it.

    ‌‌It helps you master the skill of copywriting and also teaches you to use various writing tools. Plus, it provides you with certification after completing your course.

    Conclusion

    Hence, these were the best resources to learn copywriting. Whether you are a beginner or a master, learning never has an end. The above list contains different resources which can benefit any stage-level copywriter. You just have to choose one of the resources according to your requirements, availability, and preferences and start learning and earning from copywriting.

    FAQs

    What is copywriting?

    Copywriting is the art of attracting customers by writing impressive sales or ad copies and persuading them to buy a particular brand’s product.

    What are the best resources to learn about copywriting?

    Some of the best resources to learn copywriting are:

    • CopyHackers: The Ultimate Guide to No-Pain Copywriting
    • ConversionXL: Quick Course On Effective Website Copywriting
    • Smart Blogger by Jon Morrow
    • Copywriting For Beginners by Skillshare
    • The Complete Copywriting Course by Udemy
    • Blackford Center for Copywriting

    What skills do I need to be a copywriter?

    Some of the most prominent skills that you need to be a copywriter are:

    • Research skills
    • Updated knowledge of the digital trends
    • Understanding of the target audience
    • Understanding of SEO
    • Ability to attract the readers

  • From Chaos to Success: The Mike Koshatko Story

    Sometimes “overnight success” takes many years of hard work and dedication. That’s what Mike Koshatko discovered when he moved from Ukraine to the United States with just $300 in his pocket. The only food he could afford to eat was ramen noodles. Today, he is a serial entrepreneur with successful businesses like Ofirio, an innovative real estate website.

    Mike Koshatko exemplifies a modern day “rags to riches” story beginning with the chaotic start to his life in America in 2014. He initially settled in Denver and moved cross-country multiple times in search of a better life.

    His journey included living in North Carolina, where he and some friends hitchhiked and walked for seven hours to reach a commune. A stranger helped them find a safe place to stay and allowed them to pay later. Then came North Dakota, where he lived and worked on a farm. Unfortunately for Mike, his isolation triggered a depressive episode. He then moved to Key West, where he started out as a salesman and soon moved up to a managerial position.

    But he never allowed himself to get stuck in a comfort zone. It turned out that this restlessness was his biggest advantage in business. Moving around and looking for new and better opportunities inspired Mike to seize every chance he could get, all the while learning lessons and skills along the way.

    He soon realized that if he couldn’t find the opportunities he longed for, he would have to create them for himself.

    Things finally started to turn around for Mike when he moved to Miami. He met a real estate agent who encouraged him to get into the business. He took an expedited real estate course and became a licensed realtor just two weeks later. Mike jumped at the chance to work with international real estate management clients in Europe. Always looking for the next opportunity, he launched a vacation rental management company.

    But the true start of Mike’s financial independence began when he launched his first e-commerce company. This allowed him to learn marketing, SEO, sales, conversions, and online business through courses and on the job. Most importantly, he applied everything he learned.

    After achieving success selling on Amazon, he met Jurgis Plikaitis, through a real estate listing. The two became friends and they decided to become business partners. In-depth research revealed that there was a gap in the arts and crafts market. That prompted them to start Arteza, a company that sells art supplies. At first, they started selling better quality pencils. Arteza later expanded to carry all sorts of arts and crafts products. The company grew by a whopping 7500% and landed in 32nd place out of 5000 arts and crafts stores – a massive win early in the company’s career.

    Mike and his co-founder Jurgis were working 12-hour days to keep Arteza up and running. Eventually, Mike found himself in the hospital for burnout. This event was a big lesson for him. He learned that he needed to achieve more balance in his life by incorporating breaks, taking family time – and also taking time out for himself to have some fun.

    Mike exited Arteza in 2020 and started dabbling in stocks and real estate. He quickly realized that there was a gap in the market for helping investors and individuals work out a property’s potential long-term value. This led to the startup that Mike is currently working on, Ofirio. Ofirio provides in-depth information that allows investors and individuals to look at the rental properties available and immediately see their value, the return on investment and other financial metrics. Ofirio allows people to make the best real estate investment decisions to achieve their goals.

    There are many lessons in business – and in life – that can be taken from Mike Koshatko’s story. First, it takes focus and applying what you’ve learned to achieve success. According to Mike, to succeed in your business career you need to become “comfortable with being uncomfortable,” and trust the process.

    Another takeaway is that removing yourself from your comfort zone and seeking better opportunities for yourself is what creates a better life. Mike could have chosen to stay in many positions, but instead he opted to venture out and reach for something better. He truly believes that comfort zones breed stagnancy, and stagnancy is what kills your dreams.

    Mike believes that there is no such thing as overnight success. True and sustainable success takes years of hard work. It has been eight years since Mike Koshatko began his journey. He believes in his future goals and that he still has many opportunities in front of him still to come.

  • The 18th edition of World Cloud Show presented an incisive analysis of Cloud and Data Centers in India

    The Government of India’s vision of Digital India as the engine for transition into a developed nation and an empowered society is looked upon by the rest of the world as a very optimistic and promising move. Keeping up with its ambitions and developments & further strengthening its vision, Trescon hosted its 18th global edition of World Cloud Show on 14 September 2022 in Mumbai, India.

    Co-powered by Lightstorm, and supported by NITI Aayog, the 18th edition of the World Cloud Show – India concluded after a day filled with understanding of the next phase of cloud transformation and data centers in India.

    The India edition of World Cloud Show catalyzed the development of the Indian government’s Cloud Vision, shedding light on several initiatives for the development of Cloud Computing and Data Centers in India, as well as the economic contribution that organizations supporting cloud computing are making to the country. Government officials, tech sector titans, and a stellar lineup of over 25 esteemed speakers from top international organizations were present at this event to provide their insightful feedback.

    The conference’s main themes were adapting to the new normal and managing the upcoming Cloud and Data Centers transformation. It presented divergent perspectives from a diversified industry by exchanging ideas, addressing significant learning, and emphasizing recent advancements from the corporate, government, and professional sectors.

    Some of the top speakers who took the center stage included:

    • Suresh Sankaranarayanan; Senior EVP & CTO, Kotak General Insurance
    • Nikunj Jain; CIO & Digital Leader, P&G India
    • Ekhlaque Bari; CIO Jubilant Food Works
    • Dr Avadhut Parab; Chief Information Officer, Parle Agro
    • Sourav Das; Chief Digital & Information Officer, Essel Mining – Aditya Birla Group
    • Viral Davde; Chief Technology Officer, NCDEX
    • Ananth Kumar; Engineering Leader, Site24x7
    • Vinod Kumar; EVP & Chief Information Officer, Fino Payments Bank
    • Ninad Raje; Director & Chief Information Officer, Health Assure
    • Amajit Gupta; CEO, Lightstorm
    • Vamsi Krishna Ithamraju; Chief Technology Officer, Axis Mutual fund
    • Abhishek Sukhwal; Head Cloud Center of Excellence, Mahindra & Mahindra Ltd.
    • Rajgopal Nayak; Chief Technology Officer, Metro Brands
    • Ashish Sharma; Strategy Head Special Projects, Web Werks
    • Roberto Frongia; Strategy & Operations Director Technology and Digital Compute & Innovation NEOM KSA
    • Suresh Chandrasekaran; Executive Vice President, Denodo
    • Manish Kishore; Global CIO Wockhardt ltd
    • Nasreen Khan; Head – Cloud & Cloud Security, Bharat Petroleum Corporation Ltd.

    Ninad Raje, Director & CIO, Health Assure, remarks, “If cloud technology is the soil, then Data Centers are the pipeline that supplies the water to the soil.” While shedding light on the exponential expansion of the data center market at the World Cloud Show – India, Ninad added, “In the Indian market, Data Centers are unquestionably here to stay and are committed to the long term.”

    Dr Avadhut Parab, CIO, Parle Agro, offered significant insights on the application of AI and ML, “Machine learning and artificial intelligence are no longer myths. The improvement of customer service and experience through data augmentation based on customer feedback increases brand recognition. IT and business operations are now run much more efficiently, thanks to AI and ML.”

    Suresh Chandrasekaran, Executive Vice President, Denodo, took part in a panel discussion and listed top three takeaways from the current environment in the data center industry, and said, “Before collecting data, organizations must continually connect the data. Data literacy and unified data control are required for every organization, as is the decoupling of business transformation and IT operations.”

    The various cloud models and services enabling enterprises to implement the cloud in different ways and effectively invest in technology were one of the major topics of discussion at the event. The speakers on this panel included Suresh Sankaranarayanan, Senior EVP & CTO, Kotak General Insurance; Nikunj Jain, CIO & Digital Leader, P&G India; Prasanna C, Head of Product & Marketing, Lightstorm; and Manish Kishore, Global CIO, Wockhardt Ltd.

    In this panel discussion, panellists talked about the best cloud migration approaches for companies in a variety of industries. The panel also discussed heavily on the value proposition of Kubernetes in the modern workspace and edge computing.

    Another notable panel discussion during the event covered the topic of ‘Data Centers Reimagined: AI, ML, Edge & Virtualization’. The panel examined cutting-edge data center technology and how organizations can use it to maximize the value of their data. The speakers of the panel included Dr Avadhut Parad, CIO, and Parle Agro; Sourav Das, CIDO, Aditya Birla Group. Viral Davde, CTO, NCDEX; Vinod Kumar, EVP & CIO, Fino Payments Bank.

    The panel talked about the rapid expansion of ML and AI in the Indian market. Panellists gave insights on the various tools used for the functioning of Data Centers, whilst also shedding light on the role of edge in sustainability initiatives.

    Large enterprises have diversified business functions, converged technologies have given enterprises the scalability while significantly reducing time to market,” quoted Sourav Das, CIDO, Aditya Birla Group as he shared his thoughts on converged technologies at Trescon’s World Cloud Show – India.

    Lightstorm’s Amajit Gupta gave a comprehensive presentation on the theme of powering the inevitable network. He emphasized how important it is for a network to be able to adapt to the rapidly changing environment in which we live. For organizations to succeed, modern networks and the speed at which information is sent to them are essential. “Every business owner wants to be at the vanguard of a digital revolution,” stated Mr Amajit Gupta, CEO of Lightstorm, while discussing new technological developments at Trescon’s World Cloud Show. He added, “It is a logical progression given that businesses can now sell everywhere thanks to cloud technologies. Instead of increasing their physical footprint, businesses will concentrate on growing their digital footprint.”

    Ananth Kumar, Engineering Leader, Site24x7 gave another very impactful presentation to the audience about choosing a monitoring system and various factors to consider. He highlighted the distinctions between on-prem and SaaS solutions by emphasizing the business’s cost, time, skill, and requirements.

    Basil Dhange, CISO of Aditya Birla Sun Life AMC Ltd., shared his top tips for moving to the cloud, and quoted, “It is critical to identify pain-points of on-premise before migrating to the cloud, also very important to understand your data and then embark on your cloud journey.”

    “We need to switch from a smart approach to one that is more holistic and cognitive. We are looking for innovation in every corner of the world. The Indian market is highly valued by NEOM and we intend to utilize it to advance our endeavor to accelerate human progress.”- Roberto Frongia, Strategy & Operations Director Technology and Digital Compute & Innovation NEOM KSA.

    Presenting the hybrid cloud platform of Web Werks, which scales with the expansion of businesses was Ashish Kumar, Strategy Head of Projects at Web Werks. Among the subjects covered by Mr Ashish Sharma were the data fabric, contemporary data management technologies and integration, and augmented or automated data management. A thorough presentation that addressed all the concerns and questions that several decision-makers had.

    Nasreen Khan, Head of Cloud & Cloud Security, Bharat Petroleum Corporation Ltd., commented as she moderated the panel discussion on cloud security, and said, “Cloud has a huge range. Like the weather, it is a dynamic environment that changes. As soon as your company makes the major switch to the cloud, I suggest doing routine data audits.”

    The 18th global edition of World Cloud Show is officially sponsored by:

    • Supported By: NITI Aayog
    • Co-Powered By: Lightstorm
    • Gold Partner: Site24x7 & Web Werks
    • Silver Partner: Denodo

    About Cloud Show

    World Cloud Show is a global series of events that take place in cities all over the world and are focused on business and thought leadership.

    The Indian edition of the world tour will bring together qualified CIOs, CTOs, COOs, Heads of Cloud, Heads of IT Infrastructure, Heads of Data Center Operations – IT Data Center Administrator, DevOps Leaders, Heads of Digital Transformation/Innovation, and Experts in Cloud Computing from across India’s industry verticals, all under one roof.

    About Trescon

    Trescon is a multinational business events and consulting company that offers a variety of business services to a clientele that is diverse and includes businesses, governments, and individuals. With the help of conferences, roadshows, expos, demand creation, investor connect, and advisory services. Trescon produces highly targeted B2B events that link companies with prospects.

    For further details about the announcement, please contact:

    Nupur Aswani,
    Head – Media, PR & Corporate Communications, Trescon
    media@tresconglobal.com | +91 95559 15156

  • Sun Pharma Success Story | How it became the 4th largest Pharmaceutical Company in the world?

    Company Profile is an initiative by StartupTalky to publish verified information on different startups and organizations. The content in this post has been approved by Sun Pharma.

    It was in the mid-1800s when pharma industries started by distributing botanical drugs such as morphine. Gradually, with applied research studies, the industry started picking up pace, which resulted in the development of new drugs.

    The post-world wars gave birth to a wide variety of new antibacterial drugs. Ever since pharmaceutical manufacturing companies have been significant in creating potential drugs, that many of us are familiar with in our day-to-day lives.

    In the 1980s, a lot of pharmaceutical companies started to hit up the market, and one of them was Sun Pharma. With their continuous efforts and innovations, Sun Pharma became the largest pharmaceutical company in India and the fourth-largest speciality generic pharmaceutical company in the world.

    This article covers all the suitable information related to Sun Pharma, like its success story, its founders, its key products and services, its business and revenue model, and more.

    Sun Pharma – Company Highlights

    Company Name Sun Pharmaceutical Industries Ltd.
    Headquarters Mumbai, India
    Sector Pharmaceuticals Manufacturing
    Type Public
    Founded 1983
    Founder Dilip Shanghvi
    Revenue $4.7 billion (FY22)
    Market Cap. $27.85 Billion (October 2022)
    Website sunpharma.com

    Sun Pharma -About and How Does It Work?
    Sun Pharma – Industry
    Sun Pharma – Founder and Team
    Sun Pharma – Startup Story
    Sun Pharma – Mission and Vision
    Sun Pharma – Name, Tagline, and Logo
    Sun Pharma – Business Model
    Sun Pharma – Revenue Model
    Sun Pharma – Revenue Growth
    Sun Pharma – Investments
    Sun Pharma – Mergers and Acquisitions
    Sun Pharma – Advertisements and Social Media Campaigns
    Sun Pharma – Awards and Achievements
    Sun Pharma – Competitors
    Sun Pharma – Future Plans

    Sun Pharma -About and How Does It Work?

    Sun Pharma, founded in 1983, is a global pharmaceutical firm that develops and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in over 100 countries worldwide with around 40 manufacturing facilities. Its R&D centres throughout the world, as well as a multicultural staff of over 50 nationalities. Countries like Brazil, Mexico, Russia, Romania, and South Africa are some of its key emerging markets. The company likes to promote excellence via strategic innovation, which is supported by strong R&D capabilities that include about 2,000 scientists and R&D spending of more than 7-8% of annual revenues.

    Absorica, Acamprosate Calcium, Alendronate Sodium, Amifostine trihydrate, Budesonide, and Carvedilol are among its API products. Psychiatry, anti-infectives, neurology, cardiology, orthopaedic, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dentistry, and nutrition are among the therapeutic categories served by Sun Pharma. The company claims to have more than 37,000 people employed across its global offices.

    Sun Pharma consists of having a diversified speciality and generics portfolio that further consists of nearly 2000 high-quality compounds, which is available in a variety of dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids.

    Sun Pharma was placed on the stock exchange in 1994, with an issuance that was 55 times oversubscribed. The original family still owns the bulk of the corporation.

    Sun Pharma – Industry

    One of the biggest industries in the world is the pharmaceutical industry. Moreover, as per records, the Indian Pharmaceutical industry ranks third in the world in terms of pharmaceutical production by volume.

    The pharma market has seen tremendous growth over the past few years, especially after the pandemic. The total revenue of the global pharmaceutical market was valued at $1.27 trillion in 2020.

    Top 21 Healthcare and Pharma Startups in India 2022
    The Healthcare industry is one of the most successful industries in India. Take a look at some of the most successful healthcare startups in India.
    StartupTalkyVidhi Punamiya

    Sun Pharma – Founder and Team

    Sun Pharma was founded by Dilip Shanghvi in 1983.

    Dilip Shanghvi

    Dilip Shanghvi - Founder of Sun Pharma
    Dilip Shanghvi – Founder of Sun Pharma

    Dilip Shanghvi is the founder and MD of Sun Pharmaceuticals Industries Ltd. He was born in the Indian state of Gujarat to Shantilal Shanghvi and Kumud Shanghvi in the tiny village of Amreli. Dilip Shanghvi’s career took a turn when he began by assisting his father at his business, a wholesale dealership of pharmaceuticals, primarily generic drugs in Kolkata. But later, he considered producing his pharmaceuticals rather than selling those manufactured by others. Today, he is one of the country’s richest people with a net worth of $14.3 billion. In 2016, the Indian government bestowed upon him the civilian honor of Padma Shri. After a year, India Today magazine rated him eighth on its list of the country’s most powerful persons.

    Dilip Shanghvi was nominated to the Reserve Bank of India’s 21-member central board committee in January 2018. He is also the head of the IIT Bombay board of governors. There’s a book on him, which is the first and only biography of Dilip Shanghvi, ‘The Reluctant Billionaire’ written by journalist Soma Das. The book was nominated for Tata Literature Award in the Best Business Book category in 2019. Dilip’s wife’s name is Vibha Shanghvi. The couple has two children, one daughter, and one son.

    Israel Makov

    Israel Makov was the Non-Executive Chairman of the Company. He recently retired from the company in August 2022. Before becoming a part of Sun Pharma, Israel Makov served as the President & CEO of Teva Pharmaceutical Industries Ltd from 2002 to 2007. He had directed a variety of enterprises in diverse areas before joining Teva. Among them was Interpharm, his first biotech firm, which he started and later took public in the United States.

    Israel graduated from the Hebrew University in Jerusalem with a B.Sc. in Agriculture and an M.Sc. in Economics. He is a member of the Weizmann Institute of Science’s Executive Board and Management Committee, the Technion’s Board of Governors, and a Director of Yeda Research and Development Company Ltd. Israel Makov is also the Chairman of Israel’s leading theatre, the Gesher Theatre.

    Under Israel’s leadership, the company transformed from a $1.7 billion organization operating in India and USA to the world’s fourth-largest specialty generic pharmaceutical company operating in more than 100 markets.

    Sun Pharma – Startup Story

    The startup story of Sun Pharma started in Vapi, Gujarat, which is a few hours’ drive from Mumbai. Dilip Shanghvi set up his first manufacturing plant there with a capital of Rs 10,000. In the initial days, the pharma company manufactured only psychiatry drugs but it soon scaled up its business. By 1997, the company’s business was a hit and was able to make its first acquisition by acquiring Caraco Pharma, an American company.

    At present, Sun Pharma is the market leader in fields like diabetology, cardiology, urology, gastroenterology, ortho, dermatology, vitamins, minerals, and nutrients, with nine other distinct specialties of specialists.

    Sun Pharma – Mission and Vision

    Sun Pharma’s vision is, “Reaching People And Touching Lives Globally As A Leading Provider Of Valued Medicines”

    The firm wants to offer medicines that are of prime quality and affordable to most people.

    The company follows its idealogy based on five core values:

    • Reliability
    • Trust
    • Quality
    • Innovation
    • Consistency

    Sun Pharma Logo
    Sun Pharma Logo

    The name Sun Pharma is based on the idealogy of the sun.

    The tagline of Sun Pharma reads, “Science is at the heart of Sun Pharma” The logo of the company is a symbol that is similar to the shape of the sun in bold orange and light orange colour combinations.

    Sun Pharma – Business Model

    Sun Pharma operates its business by manufacturing and selling pharmaceutical formulations and active pharmaceutical ingredients (APIs).

    Sun Pharma produces an extensive variety of therapeutic segments, specialty medicines, generic medications, and over-the-counter (OTC)/consumer healthcare products with its brand names like Faringosept for sore throat treatment, Revital (multivitamins), Volini for topical analgesics. It further includes other categories of brands such as Coldact & Flustat, Brustan, Painamol & Paduden, Gestid, Aspenter, Aspacardin, Chericof, and Nudrate & Fortifikat.

    Sun Pharma’s business operations also involve a wide range of Anti Retro Viral Medications (ARV), which are all qualified by WHO. The supplies ARVs to diverse National AIDS treatment programs in Africa. The company wants to contribute significantly to fighting HIV/AIDS by producing first-line and second-line Highly Active Antiretroviral Therapy (HAART). Its business operations are present in almost 100 countries.

    Sun Pharma CSR Activities

    Sun Pharma also focuses on serving and helping society. There are a lot of underprivileged communities in India, and Sun Pharma with its CSR activities aims to serve the community in three primary areas: health, education, safe drinking water, and sanitation.

    The CST mission of Sun Pharma is, “To leverage our people, expertise, and networks to address the needs of the communities that we serve and thereby catalyze overall development.”

    Sun Pharma has the following CSR projects:

    Malaria Elimination Demonstration Project (MEDP)

    A partnership between the Indian Council of Medical Research (ICMR), the Government of Madhya Pradesh (GoMP), and the Foundation for Disease Elimination and Control of India (FDEC India) is a non-profit enterprise with a primary focus on reducing malaria cases in over 200 villages of the Mandla district.

    Mobile Healthcare Units (MHUs)

    MHUs deliver primary healthcare services to more than 650,000 people who live near Sun Pharma’s manufacturing sites and other establishments. It offers services like health-check ups and free medicines.

    Model School Development

    This project is implemented to empower students coming from rural areas to give them the basic right to education and other development opportunities.

    Safe Drinking Water and Sanitation

    This project by Sun Pharma aims to provide access to hygienic and clean drinking water and good-quality washrooms and toilets in various regions in villages.

    Sun Pharma Science Foundation

    The Sun Pharma Science Foundation is a recognized non-profit organization under the Societies Act. This foundation gives motivation and encouragement to those who excel in the medical and pharmaceuticals line.

    Environmental, Health & Safety (EHS) programs

    The program of EHS by Sun Pharma aims an establishment of a safe and healthy workplace as well as a clean environment for all workers and the communities it serves.

    Sun Pharms CSR

    Sun Pharma’s Covid-19 initiatives

    The company was deeply engaged in providing Covid-19-specific medicines to help curb the virus and the community in general. Some of the initiatives launched by Sun Pharma are:

    • ‘Sunkalp’, is a special initiative by Sun Pharma for the welfare of doctors, their families, and the community.
    • Teamed up with MSD, popularly known as Merck in the United States and Canada. MSD gave special rights to Sun Pharma to manufacture, market, and distribute Molnupiravir in India.
    • Sun Pharma donated a sum of Rs 250 million of Hydroxychloroquine (HCQS), Azithromycin, other related drugs, and hand sanitizers in India. It has also made other donations related to Covid-19 medicines and PPEs within international boundaries.
    • Set up manufacturing units just to produce Covid-19-specific medicines such as Vecuronium (anaesthesia), Midazolam (anxiety), Ivermectin (antiviral), Azithromycin (antibiotic), and HCQS.
    • Sun Pharma launched FluGuard (Favipiravir 200 mg) in 2020. The tablet is set at an economical price of Rs 35 to treat mild to moderate Covid cases in India.

    Sun Pharma – Revenue Model

    It is reported that over 72% of Sun Pharma sales are from markets outside India, predominantly in the United States. Furthermore, the USA is the largest market area for Sun Pharma from where the company gets 30% of its total revenue from the USA markets. The revenue comes from its 44 global locations in India, the USA, Africa, Asia, Australia, and Europe.

    Sun Pharma – Revenue Growth

    Sun Pharma made a revenue of Rs 39,576 crores, which is equal to $5.0 billion in 2022. It had a net income of Rs 3,405 crores. It is reported that after deducting extraordinary items of Rs 3,935.7 crore and exceptional tax gain of Rs 76.4 crore, the adjusted net profit for the quarter was Rs 1,582.1 crore, which is up 18% year on year.

    The contribution of Sun Pharma’s global specialty business has nearly doubled from 7% of consolidated revenues in FY18 to about 13% in FY22. Moreover, the company claims that in FY22, India formulation sales were at Rs 127 Billion, up 23%, and accounted for about 33% of overall revenues. Excluding the contribution of COVID products, the underlying business of Sun Pharma performed well, with about 20% growth over the previous year.

    Sun Pharma – Investments

    Sun Pharma has invested in four companies. Their investment is in Zenotech Laboratories, a pharmaceuticals company in India, which raised ₹53.2 million on March 21, 2022. Following is the list of investments by Sun Pharma:

    Date Company Name Amount Invested
    March 21, 2022 Zenotech Laboratories ₹53.2 million
    September 10, 2018 Tarsier Pharma $3 million
    August 8, 2017 Krystal Biotech $7 million
    January 4, 2017 scPharmaceuticals $45.6 million

    Sun Pharma – Mergers and Acquisitions

    Sun Pharma has bought seven companies. POLA-Pharma was their most recent purchase, which occurred on November 27, 2018. The acquisitions are:

    Date Acquiree name Amount
    November 27, 2018 POLA-Pharma –
    July 28, 2017 Zenotech Laboratories ₹855 million
    November 23, 2016 OJSC Biosintez $24 million
    October 27, 2016 Ocular Technologies Sarl $40 million
    September 15, 2015 InSite Vision $48 million
    April 6, 2014 Ranbaxy Laboratories $3.2 billion
    November 9, 2012 DUSA Pharmaceuticals $230 million

    Sun Pharma – Advertisements and Social Media Campaigns

    With a strong social media presence, Sun Pharma has launched multiple campaigns related to its brands. In 2021, Sun Pharma ran an advertisement about their brand Revital, titled: REVITAL H 21 Days Challenge with the #rahocharged. The advertisement features Bollywood Actor Akshay Kumar promoting their multivitamin supplement product Revital. The ad by Sun Pharma promotes taking up the 21 days challenge by having revital to feel energized in just 21 days.

    During the pandemic, Sun Pharma released a thank you campaign titled: Sun Family Stands United With All Corona Warriors to extend their support to every frontier to stay united and fight against the Covid-19 pandemic.

    Sun Pharma – Awards and Achievements

    Some of the awards and milestones of Sun Pharma in recent years are:

    2022

    • Sun Pharma was recognized as the No. 1 generic pharmaceutical company by patient groups in the annual PatientView ‘Corporate Reputation of Pharma’ survey 2021
    • Acquired the Uractiv portfolio from Fiterman Pharma in Romania

    2021

    • Sun Pharma bagged the DIANA (Distribution Industry Award for Notable Achievements in Healthcare) award for ‘Best New Product Introduction/Promotion’
    • Sun Pharma received the Golden Peacock Award for Corporate Social Responsibility, 2020
    • Received the Best Innovative Company of the Year 2021 at Indo-American Corporate Excellence Awards.
    • Launched a specialty dermatology product called WINLEVI in the U.S. for topical treatment of Acne Vulgaris

    2020

    • Sun Pharma was listed among the Forbes World’s Best Employers 2020

    2019

    • Sun Pharma was ranked No. 1 in the pharma sector and No. 16 overall in the BW Businessworld list of India’s Most Respected Companies
    • Sun Pharma acquired Pola Pharma in Japan to strengthen its global dermatology presence
    • Sun Pharma Foundation for Disease Elimination and Control of India received the Mahatma Award for Social Good in 2019

    2018

    • Sun Pharma received the Best CSR Practices Award from The Economic Times
    • Sun Pharma was listed among the Forbes World’s Best Employers

    Sun Pharma – Competitors

    Here is the list of top competitors of Sun Pharma:

    1. Dr. Reddy’s Laboratories
    2. Divi’s Laboratories
    3. Cipla Limited
    4. Torrent Pharma
    5. Gland Pharma Ltd.
    6. Abbott India
    7. Alkem Lab
    8. Aurobindo Pharma Ltd.
    9. Zydus Lifesciences Ltd.
    10. Lupin Ltd.
    11. Ajanta Pharma
    12. Pfizer
    13. Glenmark Pharma Ltd.
    14. P&G

    Sun Pharma – Future Plans

    Sun Pharma has mentioned in its future plans that its top focus area for FY23 is to ramp up its global specialty business. It also plans to have a business expansion that is both sustainable and lucrative. The company is planning to have a proper maintaining supply chain continuity while focusing on inventory management along with increasing investments in IT to allow business and digital transformation and to improve overall return ratios.

    FAQs

    Is Sun Pharma the top most Indian pharma company?

    Yes, Sun Pharma is the top pharma company in India in terms of market capitalization.

    Revital is among one of the most popular products by Sun Pharma.

    Who is the CEO of Sun Pharma?

    Kal Sundaram is the current CEO of Sun Pharma.

    Where is the head office of Sun Pharma?

    The head office of Sun Pharma is in Goregaon, Mumbai.